Molecular regulation of embryonic mammary gland development by Voutilainen, Maria
Molecular Regulation of Embryonic Mammary 
Gland Development
INSTITUTE OF BIOTECHNOLOGY
RESEARCH PROGRAM IN DEVELOPMENTAL BIOLOGY 
AND
DIVISION OF GENETICS
DEPARTMENT OF BIOSCIENCES
FACULTY OF BIOLOGICAL AND ENVIRONMENTAL SCIENCES
DOCTORAL PROGRAMME IN INTEGRATIVE LIFE SCIENCE
UNIVERSITY OF HELSINKI
MARIA VOUTILAINEN
DISSERTATIONES SCHOLAE DOCTORALIS AD SANITATEM INVESTIGANDAM 
UNIVERSITATIS HELSINKIENSIS 3/2015
3/2015Helsinki 2015                             ISSN 2342-3161         ISBN 978-951-51-0569-1
 M
A
R
IA
 V
O
U
T
IL
A
IN
E
N
    M
olecu
lar R
egu
lation
 of E
m
bryon
ic M
am
m
ary G
lan
d
 D
evelop
m
en
t
Recent Publications in this Series
33/2014 Salla Jaakkola
Evolution in Salt: Genomic and Structural Approaches to Halophilic archaea and Their Viruses
34/2014 Kati Ahlqvist
The Effects of Mitochondrial DNA Mutagenesis on Somatic Stem Cells and Ageing
35/2014 Liisa Lilja-Maula
Canine Idiopathic Pulmonary Fibrosis in West Highland White Terriers: Natural History and 
TGF-β Related Molecular Pathways
36/2014 Saija Ahonen
Canine Models of Human Vision Disorders: Identifi cation of New Loci and Genes for Glaucoma 
and Retinal Degeneration
37/2014 Liisa Uotila
Regulation of Leukocyte Integrin Binding to Ig-Family Ligand
38/2014 Juha Kuja-Panula
AMIGO and Its Friends in Developing and Adult Brain
39/2014 Enzo Scifo
Systematic Analysis of Disease Pathways in Congenital, Infantile and Juvenile Neuronal Ceroid 
Lipofuscinoses
40/2014 Ida Surakka
Genetics of Circulating Blood Lipids
41/2014 Juho Miettinen
Activation of Innate Immune Response in Human Macrophages by Herpes Simplex Virus-1 and 
Crystallized Monosodium Urate
42/2014 Sari Mölsä
Long-Term Outcome in Dogs After Surgical Repair of Cranial Cruciate Ligament Disease
43/2014 Vassilis Stratoulias
Studies on the Neurotrophic Factor Manf and the Pleiotropic Factor Lin-28 during Drosophila 
Development
44/2014 Mikko Koskinen
F-Actin Dynamics in Dendritic Spines
45/2014 Robertas Ursache
Novel Regulators of Vascular Development in Arabidopsis thaliana
46/2014 Elisa Kallio
Lipopolysaccharide: a Link between Periodontitis and Cardiometabolic Disorders
47/2014 Tuomas Lilius
New Insights into Enhancing Morphine Analgesia: from Glia to Pharmacokinetics
48/2014 Anmol Kumar
Role of 3’UTR in the Regulation of Neurotrophic Factors BDNF and GDNF
49/2014 Yuezhou Zhang
Investigating Phosphate Structural Replacements through Computational and Experimental 
Approaches
1/2015 Bjørnar den Hollander
Neuropharmacology and Toxicology of Novel Amphetamine-Type 
Stimulants
2/2015 Jenni Vanhanen
Neuronal Histamine and H3 Receptor in Alcohol-Related Behaviors 
– Focus on the Interaction with the Dopaminergic System
Molecular Regulation of Embryonic Mammary
Gland Development
Maria Voutilainen
Research Program in Developmental Biology
Institute of Biotechnology
University of Helsinki
and
Division of Genetics
Department of Biosciences
Faculty of Biological and Environmental Sciences
University of Helsinki
and
Doctoral Programme in Integrative Life Science
University of Helsinki
ACADEMIC DISSERTATION
To be presented for public examination with the permission of the Faculty of Biological and 
Environmental Sciences of the University of Helsinki in auditorium 2 in Information Cen-
tre Korona (Viikinkaari 11, Helsinki) on February 13th 2015, at 12 noon
Helsinki 2015
Supervisor  Docent Marja Mikkola
   University of Helsinki, Finland
Advisory committee Docent Marjo Salminen
   University of Helsinki, Finland
   and
   Professor Hannu Sariola
   University of Helsinki, Finland
Pre-examiners  Docent Marjo Salminen
   University of Helsinki, Finland
 
   and
   Professor Matti Poutanen
   University of Turku, Finland
Opponent  Professor Pamela Cowin
   New York University School of Medicine, USA
Custodian  Professor Juha Partanen
   University of Helsinki, Finland
Cover image: Carmine alum stained wild type mammary gland at embryonic day 18 
Published in Dissertationes Scholae Doctoralis Ad Sanitatem Investigandam Universitatis 
Helsinkiensis
ISBN 978-951-51-0569-1 (paperback)
ISBN 978-951-51-0570-7 (PDF)
ISSN 2342-3161 (Print)
ISSN 2342-317X (Online)
Cover layout by Anita Tienhaara
Press: Hansaprint, Vantaa 2015
      
   Somewhere, something 
incredible is waiting to be known.
-Carl Sagan 
Table of Contents
List of original publications
Abbreviations
Summary
1 Review of the literature ....................................................................................................................1
 1.1 Mammary gland as an ectodermal organ ..............................................................................1
  1.1.1 Branching morphogenesis .........................................................................................1
 1.2 Molecular regulation of morphogenesis and signalling pathways involved 
  in mammogenesis .....................................................................................................................1
  1.2.1  Fibroblast growth factor pathway .............................................................................2
  1.2.2  Wnt pathway. ...............................................................................................................2
  1.2.3  Transforming growth factor β pathway ...................................................................3
  1.2.4  Epidermal growth factor pathway ............................................................................3
  1.2.5  Sonic hedgehog pathway ...........................................................................................3
  1.2.6  Pthrp pathway. ............................................................................................................3
 1.3  Ectodysplasin .............................................................................................................................4
  1.3.1  Eda signal transduction .............................................................................................4
  1.3.2  Eda defi ciency and Hypohidrotic ectodermal dysplasia .......................................5
  1.3.3  Eda gain-of-function mouse models .......................................................................6
  1.3.4  Natural variation in Eda signalling ..........................................................................7
  1.3.5  Expression of Eda pathway components .................................................................7
  1.3.6  Molecular targets of Eda ............................................................................................7
 1.4  Mammary gland development ................................................................................................8
  1.4.1  Morphological development .....................................................................................8
  1.4.2  Molecular regulation of development ....................................................................11
  1.4.3  Postnatal development .............................................................................................15
 1.5 Variations in mammary gland number ................................................................................17
  1.5.1  Supernumerary mammary glands in humans ......................................................17
 1.6 Relevance of embryonic mammary gland development to breast cancer .......................18
2 Aims of the study .............................................................................................................................19
3  Materials and methods ...................................................................................................................20
4 Results and discussion ....................................................................................................................23
 4.1  Ex vivo culture of mammary primordia (I, II, III) ..............................................................23
 4.2 Eda promotes mammary placode formation and enhances prepubertal 
  branching morphogenesis (II,III) .........................................................................................25
 4.3 NF-κB mediates eff ects of Eda during mammary primordia development (II,III) ........29
 4.4  Identifi cation of Eda/NF-κB downstream targets in mammary primordia (II,III) ........31
 4.5  Eda upregulates Wnt activity which mediates its eff ects on 
  mammary primordia (II,III) ..................................................................................................32
 4.6 Overexpression of Eda leads to loss of sexual dimorphism in the mammary
  glands (III)   .............................................................................................................................34
5 Concluding remarks .......................................................................................................................36
Acknowledgements.................................................................................................................................38
References .................................................................................................................................................40
List of original publications
I Voutilainen M, Lindfors PH, Mikkola ML. Protocol: ex vivo culture of mouse embryonic 
mammary buds. 2013. Journal of mammary gland biology and neoplasia 18(2):239-45.
II  Voutilainen M, Lindfors PH, Trela E, Lönnblad D, Shirokova V, Rysti E, Schmidt-Ullrich 
R,  Schneider, Mikkola ML. Ectodysplasin/NF-κB promotes mammary cell fate via Wnt/β 
-catenin pathway. Manuscript.  
III Voutilainen M, Lindfors PH, Lefebvre S, Ahtiainen L, Fliniaux I, Rysti E, Murtoniemi 
M, Schneider P, Schmidt-Ullrich R, Mikkola ML. 2012. Ectodysplasin regulates hormone-
independent mammary ductal morphogenesis via NF-κB. Proceedings of the National 
Academy of Sciences 109(15):5744-9.
Th is thesis is based on original publications, which in the text are referred to by their Roman 
numerals
Abbreviations  
ADAMTS   A Dissintegrin And Metalloproteinase with Th rombospondin Motifs 
AR    Androgen receptor
AREG    Amphiregulin
BMP    Bone morphogenetic protein
DKK    Dickkopf
E    Embryonic day
ED    Ectodermal dysplasia
EDA    Ectodysplasin, Eda-A1
EDAR   Ectodysplasin A1 receptor
EDARADD   Edar-associated death domain
EdU   5-ethynyl-2’-deoxyuridine 
EGF    Epidermal growth factor
EPGN    Epigen
FGF   Fibroblast growth factor
GLI   Glioma-associated oncogene homolog
HED   Hypohidrotic ectodermal dysplasia
HH   Hedgehog protein family
IκB    Inhibitor of kappa B 
IKK   IκB kinase complex
ISH    In situ hybridization
JNK    c-Jun N-terminal kinase
K14    Keratin-14 promoter
KRM   Kremen, kringle Containing Transmembrane Protein
LEF-1    Lymphoid enhancer-binding factor 1
LGR    Leucine-rich repeat-containing G protein-coupled receptor
LRP    Low-density lipoprotein receptor-related protein
MAD-CAM   mucosal vascular addressin cell adhesion molecule 
MMP    Matrix metalloproteinase
MMTV   Mouse mammary tumour virus
MSX    vertebrate homolog of Drosophila muscle segment (Msh) 
   homeobox gene
NF-κB    Nuclear factor kappa-B
NEMO    NF-κB Essential Modulator (=IKKγ)
NRG    Neuregulin
PTHRP   Parathyroid hormone-related protein
RANKL   Receptor activator of Nf-κb-ligand
R-SPONDIN   Reelin domain-containing spondin
RISH    Radioactive in situ hybridization
RT-PCR   Reverse transcriptase polymerase chain reaction
SHH    Sonic hedgehog
SOSTDC1   Sclerostin domain-containing 1
TGFβ    Transforming growth factor β
TNF    Tumour necrosis factor
TNFR    Tumour necrosis factor receptor
TRAF   TNF-receptor associated factor
TBX    T-box
XEDAR   Ectodysplasin A2 receptor
XLHED   X-linked hypohidrotic ectodermal dysplasia
WMISH  Whole mount in situ hybridization
WNT    Wnt- family member
WT    Wild type
Summary
Mammary gland development begins during embryogenesis with the formation of species-
typical number of mammary placodes that emerge along the fl anks of the embryo at conserved 
positions. By birth, the mammary primordium has undergone branching morphogenesis and 
displays a small ductal tree with several branches. Th e organ development and growth continues 
throughout postnatal life and the mammary gland matures to functional form only during 
pregnancy and following lactation. Ectodysplasin (Eda), a member of the tumour necrosis factor 
family, is one of the key regulators of epithelial appendage development in all vertebrates. In 
humans, mutations in the Eda gene, or in other components of the signalling pathway, cause 
hypohidrotic ectodermal dysplasia (HED), a disorder characterized by sparse hair, missing teeth, 
and defects in several exocrine glands including the breast. Previous studies have shown that 
transgenic overexpression of Eda (K14-Eda mice) in the developing ectoderm leads to formation 
of ectopic mammary placodes, which give rise to supernumerary glands in the adult mice. 
Otherwise, eff ects of Eda signalling in the mammary gland have been fairly unknown. 
Here I have analysed the role of Eda in prepubertal mammary gland development. 
Characterization of the mammary glands of Eda gain- (K14-Eda) and loss-of-function (Eda 
−/−) mice revealed that the branching morphogenesis of the organs correlated with Eda levels. 
Overexpression of Eda induced precocious and accelerated branching whereas lack of Eda 
reduced number of ductal tips. Furthermore, Eda induced supernumerary mammary placode 
formation not only on the fl ank but also in the neck region. Analysis of the mouse line with 
suppressed NF-κB signaling (IκBαΔN mice) revealed that the transcription factor is a major 
mediator of Eda in the mammary gland. NF-κB activity was shown to be necessary for the 
ability of Eda to induce supernumerary mammary primordia and to accelerate branching 
morphogenesis. With a candidate gene approach and genome wide-profi ling several potent Eda 
target genes were identifi ed in the mammary gland. Among them were members of the Wnt/β-
cat pathway. Th e obtained results suggest that Eda promotes mammary cell fate by enhancing 
canonical Wnt pathway activity and other eff ects of Eda are cooperatively mediated by certain 
Wnt family members in addition to other factors. To study mammary placode formation and 
branching morphogenesis and to assess roles of individual downstream factors or pathways, ex 
vivo culture systems were developed and utilized in this thesis work. 
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1.1  Mammary gland as an ectodermal organ
Mammary glands are ectodermal organs, a group of epithelial appendages that include many 
exocrine glands such as salivary and sweat glands along with a large repertoire of other skin 
derivatives like hair, teeth, scales, feathers, nails and horns. Induction and early growth of the 
organs during embryogenesis involves highly similar morphological aspects even though 
their mature form and purpose varies enormously (Biggs and Mikkola, 2014). Th e fi rst sign 
of morphogenesis is the appearance of a local lens-shaped epithelial thickening referred to as 
a placode, which is a shared feature in the early development of all ectodermal appendages. 
Invagination of the placode into the underlying mesenchyme produces a bud. Sequential 
growth followed by organ-typical branching or folding of the epithelium gives rise to distinctive 
structures such as the small, branched ductal tree of a nascent mammary gland (Biggs and 
Mikkola, 2014;Howard, 2012). 
Th e same molecular pathways have been co-opted to function in the organogenesis of 
several ectodermal organs, which in part is thought to refl ect their common evolutionary history. 
Dysfunction of many signalling pathways may lead to defects in multiple epithelial appendages, 
a condition called ectodermal dysplasia (Itin, 2014). Sequential and reciprocal interaction 
between the epithelium and the underlying mesenchyme is essential for proper development of 
all ectodermal organs (Biggs and Mikkola, 2014;Howard, 2012). 
1.1.1  Branching morphogenesis
Branching morphogenesis is a frequently utilized developmental program to achieve a large 
surface area in a wide spectrum of organs. It is typical to some but not restricted to ectodermal 
organs. Many structures, ranging from invertebrate’s tracheal system to vertebrate mammary 
gland and lung, accomplish extensive exchange or production of substances in an organ of 
considerably small volume compared to its total epithelial surface area. Despite the unique 
characteristics of the organs, a conserved set of molecular regulators are utilized in their 
morphogenesis. In most cases, successful epithelial development relies on supportive and 
sustaining signals or chemo-attractant cues that originate from the surrounding mesenchyme 
(Lu and Werb, 2008;Varner and Nelson, 2014).
Branch pattern refers to organ-specifi c features such as branch initiation point and length 
and diameter of the ducts. In the lung the branch pattern is stereotypic and is governed by tight 
genetic regulation, whereas in a mammary gland the induction of specifi c branches appears not 
to be predetermined. Inhibitory eff ects of the pre-existing tips for example are thought to prevent 
induction of new branches in close proximity of the existing ones during pubertal branching 
morphogenesis (Lu and Werb, 2008). 
1.2  Molecular regulation of morphogenesis and signalling 
pathways involved in mammogenesis 
Cells of an organism do not live in isolation but instead are in constant interaction with each 
other. Cell populations that carry out specifi c functions and have similar origins give rise to 
tissues that in turn join together to form the organs of an individual. Cell and tissue diversity 
is achieved in stages through diff erentiation from nascent to more committed cells. It involves 
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requisite for maintaining homeostasis later on.  
Cells communicate via various signalling molecules that form pathways which in turn 
form more complex networks. Commonly a signalling molecule is a ligand that binds to a 
specifi c receptor, which triggers intracellular signalling cascades to exert the message. Signalling 
cascades are typically controlled in multiple phases by various negative or positive regulators 
that can amplify or inhibit the signal transduction. Oft en the cellular response is an activation of 
transcription factors that bind to the enhancer or promoter regions of a downstream gene. Th is 
leads to modulation of gene expression that can be either suppressive or activating. Eventually the 
received signal is either forwarded to other cells or interpreted as a change in cellular processes 
such as proliferation, apoptosis, cell shape changes or migration.
Many signalling molecules are soluble, which allows them to diff use to the surroundings. 
Th e regulatory molecules can be sensed by nearby cells, referred to as paracrine signalling, or 
aff ect the signal-producing cell in an autocrine manner. For example the epithelial-mesenchymal 
crosstalk during ectodermal organ development relies on soluble signalling factors acting via 
paracrine signalling. Additionally, cell interaction can also occur via direct cell-cell contact 
(Biggs and Mikkola, 2014;Gilbert, 2010). 
During development multiple signalling molecules are typically co-produced by transitory 
signalling centres. Th e mammary placode for instance expresses several signalling molecules 
that can have either activating or inhibiting eff ects on the placode itself or on the surrounding 
area. According to the reaction-diff usion model these factors can have unequal diff usion and 
diff erent stabilities. Th is is thought to enable placode-promoting factors to be maintained in 
a higher level within the structure and inhibitors to diff use further away, which localizes the 
placode-promoting cues to the developing organ primordia. Th is in turn is necessary for correct 
spatial patterning of the organs (Biggs and Mikkola, 2014;Kondo and Miura, 2010). 
Th e competence of cells to receive, interpret and respond to the signals from the 
microenvironment is vital for proper development as well as for maintaining homeostasis of 
a system or an organ. Faulty information-processing by the cell can lead to defects in normal 
development or be responsible for the occurrence of diseases such as cancer (Gilbert, 2010).
1.2.1  Fibroblast growth factor pathway
Fibroblast growth factor (Fgf) family proteins bind to specifi c receptor tyrosine kinases. In 
mammals Fgf receptors (Fgfr) are encoded by four genes (Fgfr1-4). Fgfr1–Fgfr3 can undergo 
alternative splicing to generate two distinct isoforms, b and c (Itoh and Ornitz, 2011). In vitro 
studies have shown that Fgfs do not bind exclusively to one receptor type but interact with several 
diff erent Fgfrs with varying affi  nity. Fgfrs signal as dimers that are formed upon ligand binding. 
Stimulation of the pathway leads to a series of intracellular phosphorylations that trigger four 
distinct signal transduction pathways: MAPK, PI3K, STAT and phospholipase Cγ (Turner and 
Grose, 2010).
1.2.2  Wnt pathway
Wnt ligands are secreted signalling molecules that bind to a receptor complex comprising 
a transmembrane Frizzled receptor and co-receptor Lrp5 or Lrp6. To date Wnts have been 
described to activate three distinct pathways (Komiya and Habas, 2008). Since the non-canonical 
planar cell polarity and calcium-mediated pathways have, thus far, not been shown to be 
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3essential for prepubertal mammary gland development (Boras-Granic and Hamel, 2013), they 
will not be described here further. Th e canonical Wnt/β-catenin (Wnt/β-cat) pathway regulates 
intracellular β-cat levels and activity of the Lef1/Tcf transcription factors that are kept inactive 
in unstimulated cells by a specifi c repressor protein. In the absence of ligand a multiprotein 
destruction complex consisting of Axin, CK1, GSK3β, and APC, ubiquitylates cytoplasmic β-cat 
which becomes proteolytically degraded. Receptor complex activation leads to inhibition of β-cat 
phosphorylation. Th is enables its cytoplasmic accumulation and translocation to nucleus. As 
β-cat binds to Lef1/Tcf proteins it displaces the repressor protein and the newly formed complex 
is transcriptionally active (Niehrs, 2012). R-spondins are secreted Wnt agonists and ligands of 
Lgr receptors (Lgr4-6). Th ough R-spondins do not initiate Wnt signalling, they potentiate it 
(Cruciat and Niehrs, 2013;de Lau et al., 2012).
1.2.3  Transforming growth factor β pathway
Th e transforming growth factor beta (Tgf-β) family consists of several members, including 
the bone morphogenetic proteins (Bmp). Tgf-β ligands activate their receptors as dimers. Th e 
signalling pathway receptors are heterodimeric complexes that compose type I and type II 
subunits with serine/threonine kinase domains. Ligand-activated receptors eventually initiate a 
Smad-dependent signalling cascade (Kamato et al., 2013;Massague, 2000).
1.2.4  Epidermal growth factor pathway
Th e epidermal growth factor (Egf) family includes proteins such as Egf itself, Amphiregulin 
(Areg) and Epigen (Epgn) as well as Neuregulin (Nrg) family members. Th ese molecules activate 
transmembrane tyrosine kinase receptor ErbB proteins. Egf, Areg and Epgn signal through 
ErbB1 (Egfr) whereas Nrgs bind to the ErbB3 and ErbB4 receptors. ErbB2 does not bind directly 
to ligands but instead is in a conformation that resembles the ligand-activated state. Activated 
receptors undergo dimerization and phosphorylation that ultimately triggers intracellular PI3K 
and MAPK pathways (Arteaga and Engelman, 2014;Olayioye et al., 2000;Wilson et al., 2012).
1.2.5  Sonic hedgehog pathway
Sonic hedgehog (Shh) is a member of the Hedgehog (Hh) family. In canonical Hedgehog 
signalling, transmembrane proteins Patched (Ptch) and Smoothened (Smo) mediate signal 
transduction. In the absence of a ligand Ptch represses Smo. Hh binding to Ptch relieves 
its inhibitory action on Smo, which allows further signal transduction by the Gli family of 
transcriptional activators and repressors (Gli1-Gli3).  Gli1 encodes transcriptional activator, 
whereas Gli2 and Gli3 are activators of the pathway in the presence of positive Hh signalling but 
are cleaved to render transcriptional repressors in the absence of Hh (Sasai and Briscoe, 2012). 
1.2.6  Parathyroid hormone-related protein pathway
Parathyroid hormone-related protein (Pthrp) is encoded by the Pthlh gene. It is structurally 
related to a parathyroid hormone commonly known as a regulator of circulatory calcium levels. 
Pthrp binds a distinct G protein-coupled receptor Pthr1. Th e receptor signals via several diff erent 
intracellular secondary-messenger systems to regulate target gene expression (Vilardaga et al., 
2011;Wysolmerski, 2012).
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41.3  Ectodysplasin
Ectodysplasin (Eda) belongs to the tumour necrosis factor (Tnf) superfamily. Eda gene gives 
rise to two biologically active splice variants, Eda-A1 and Eda-A2 that signal through distinct 
receptors, Edar and Xedar, respectively (Yan et al., 2000). Eda-A1 (hereaft er Eda) has a well-
characterized role in the morphogenesis of several ectodermal organs, whereas the physiological 
function of Eda-A2 is poorly understood (Lefebvre and Mikkola, 2014) and thus will not be 
discussed here further.
1.3.1  Eda signal transduction
Eda is a trimeric type II membrane protein. Th e extracellular portion consists of a cleavage site for 
furin enzyme, a collagen domain and the C-terminal TNF homology domain that is responsible 
for receptor binding. Release from the cell surface is required for the biological activity of Eda. 
Upon proteolytic cleavage by furin, Eda is shed from the cell membrane, which allows its diff usion 
to the site of transmembrane receptor Edar (Elomaa et al., 2001). Ligand-stimulated Edar 
interacts via intracellular adapter protein Edaradd which links the receptor to the downstream 
signalling cascade (Figure 1). Several lines of evidence have shown the role of the transcription 
factor nuclear factor-kB (NF-κB) as an important downstream eff ector of Eda (Mikkola, 2009), 
but other downstream mediators, in particular the c-Jun N-terminal kinase (JNK) have also been 
implicated (Kumar et al., 2001). In unstimulated cells, NF-κB is retained in the cytosol by IκB 
inhibitory proteins, most commonly by IκBα. Upon ligand binding, Edaradd becomes associated 
with Trafs (Tnfr-associated factors), mainly Traf 6. Recruitment of Tab2 (Tak1-binding protein 
2) and Tak1 (Tgfβ-activated kinase 1) to the signalling cascade mediates the activation of IκB-
kinase (IKK) complex, which is composed of two catalytic subunits, IkappaB kinase alpha (IKKα 
or Ikk1) and beta (IKKβ) and a regulatory protein NF-kappa-B essential modulator (Nemo or 
IKKγ). IKK complex phosphorylates the IκB inhibitory proteins (Morlon et al., 2005;Perkins, 
2007), which leads to their subsequent degradation and releases NF-κB for nuclear translocation, 
thereby permitting transcriptional regulation of the target genes (Perkins, 2007).
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5Figure 1. Th e Eda signalling pathway. 
In unstimulated cells NF-κB is bound to IκB (mostly IκBα) inhibitory proteins. Ligand binding to 
Edar receptor initiates the Edaradd-mediated intracellular signalling cascade. Activated IKK complex 
phosphorylates IκBs that become proteolytically degraded. Th is enables nuclear translocation of NF-κB. 
Th e mammalian NF-κB family includes fi ve structurally related transcription factors (p65 or 
RelA, RelB, c-Rel, p50/p105 and p52/p100) (Gilmore, 2006;Verma et al., 1995). Th eir shared 
sequence homology is responsible for DNA binding, dimerization of the factors and association 
with the IκB inhibitory proteins. NF-κB can be activated by two distinct pathways. Th e canonical 
pathway described above, which operates with dimers composed of RelA or c-Rel, and p50, has 
been implicated in Eda signalling (Kowalczyk-Quintas and Schneider, 2014). Th e alternative, 
non-canonical pathway does not require the IKK complex but instead relies only on IKKα. IKKα 
activation leads to protelolytic processing of p100 to p52 which typically associates with RelB to 
regulate transcription (Scheidereit, 2006). 
1.3.2  Eda deficiency and Hypohidrotic ectodermal dysplasia
Th e Eda signalling pathway is vital for ectodermal organogenesis and largely conserved in all 
studied vertebrate species. Disruption of Eda signalling causes hypohidrotic ectodermal dysplasia 
(HED), which leads to defective ectodermal appendage formation even across taxa (Drew et al., 
2007;Harris et al., 2008;Kondo et al., 2001;Mikkola, 2009).  
Mutations in the murine X-chromosomal Eda, and autosomal Edar or Edaradd have been 
identifi ed in mouse models Tabby (Eda null, hereaft er Eda −/−) Downless, Sleek (Edar defi cient) 
and Crinkled (Edaradd defi cient) that share highly similar or nearly identical phenotypes 
(Falconer, 1952;Gruneberg, 1971;Headon et al., 2001;Sofaer, 1969;Yan et al., 2002). Th e Eda −/− 
is the most extensively studied of them. Characteristic features of these mice include the lack 
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or malformation of dentition and defects in hair development. Several exocrine glands are also 
aff ected to varying degrees (Gruneberg, 1965;Gruneberg, 1971;Mikkola, 2009). Mutation of 
Traf6 gives rise to a remarkably similar ectodermal phenotype, as does the loss of NF-κB activity 
in a mouse strain that expresses a non-degradable form of the IκBα inhibitory protein (Naito 
et al., 2002;Schmidt-Ullrich et al., 2001). Similarities between the diff erent loss-of-function 
phenotypes further indicate a mutual dependency of the factors in Eda pathway activation. 
In humans the X-linked hypohidrotic ectodermal dysplasia (XLHED) is the most common 
form of a vast spectrum of nearly 200 ectodermal dysplasias (Kere et al., 1996;Visinoni et al., 
2009). Th e most typical features are sparse hair and missing or malformed teeth. Additionally 
many exocrine glands, such as salivary and sweat glands, among others, are absent or function 
inadequately, which leads to reduced secretion of saliva and heat intolerance due to the inability 
to perspire. Especially aff ected children are prone to perilously high fever due to the impaired 
ability to sweat (Mikkola, 2009). Anomalies of the breasts, though reported occasionally, have 
thus far not been documented to the same extent as other developmental defi ciencies (Clarke et 
al., 1987).
Prevalence of XLHED in human population has been estimated to range from 1:4500 to 
1:62000 (Nguyen-Nielsen et al., 2013). Th e phenotypically similar but autosomally inherited 
form of HED is caused by defects in the genes coding for the other members of the signalling 
pathway; receptor Edar and adaptor protein Edaradd (Headon and Overbeek, 1999;Headon et 
al., 2001;Srivastava et al., 1997). Additionally hypomorphic mutations in NEMO or IκBα lead 
to HED accompanied by an impaired immune system (Courtois et al., 2003;Doffi  nger et al., 
2001;Zonana et al., 2000). As the EDA gene is X-chromosomal, the syndrome is most oft en 
reported in men, whereas women are commonly carriers of the condition. Th e relatively rare 
autosomal forms aff ect both sexes equally and can be either dominant or recessive. Female 
carriers of XLHED and all patients with autosomal dominant HED usually display milder forms 
of the disease and oft en exhibit only slight manifestations of the cardinal traits (Mikkola, 2009).
Beyond managing the symptoms, no treatment of the condition is commonly available. 
However, introduction of recombinant Eda protein engineered to cross the placental barrier 
to Eda−/− female mice during gestation permanently corrects many of the defects (Gaide and 
Schneider, 2003). Similar correction of the phenotype has been achieved in a dog model for HED 
with administration of the protein during the fi rst postnatal weeks (Casal et al., 2007; Mauldin et 
al., 2009). Th e fi rst clinical trials on new-born babies to compensate for the absent EDA protein 
with a pharmacological substitute have been ongoing since 2013 (Huttner, 2014).  
1.3.3  Eda gain-of-function mouse models
In contrast to lack of Eda, increased Eda levels stimulate ectodermal organ development. K14-
Eda mice overexpress Eda under the K14-promoter which drives expression of the transgene 
into the ectoderm and later to the basal layer of the skin from mid-gestation (embryonic day 
9.5, E9.5) onwards. Th e mouse model has alterations in the shape and number of several skin 
appendages already during embryonic morphogenesis (Mustonen et al., 2003). Typically the 
hair and tooth placodes are enlarged. Additionally, the mice develop an ectopic molar placode 
in the oral epithelium and usually two to three supernumerary mammary placodes within the 
mammary-forming region. At least some of these accessory structures gradually transform into 
rudimentary organs present in the adult animal (Kangas et al., 2004;Mustonen et al., 2004). 
Furthermore, embryonic salivary glands display accelerated branching morphogenesis (Häärä et 
7al., 2011). Adult mice have increased sweat production, enlarged sebaceous glands, altered hair 
composition and higher complexity of endogenous dentition (Kangas et al., 2004;Mustonen et 
al., 2003;Mustonen et al., 2004). 
In addition to K14-Eda mice, another gain-of-function mouse model has been generated. It 
harbours multiple copies of the entire Edar locus (EdarTG951). Th ese mice have highly-branched 
mammary glands in adolescence. Also other exocrine glands are aff ected. Th e sebaceous and 
meibomian glands are enlarged and the salivary glands exhibit more elaborate branching (Chang 
et al., 2009). Whether the observed phenotypes are a result of altered embryonic development or 
caused by later morphological changes was not studied. 
1.3.4  Natural variation in Eda signalling 
Ectodermal appendages display variation in density and morphology within diff erent 
populations of a species. As various skin derivatives are at the forefront between an individual 
and environment, the morphological evolution of the organs provides the means for adapting to 
a particular habitat. An alternative Eda allele has been shown to give rise to the diff erences in the 
body armour between stickleback fi sh in either marine or fresh water surroundings (Colosimo 
et al., 2005). In modern human populations, an EDAR gain-of-function coding variant (V370A) 
has been associated with a thicker hair phenotype, altered tooth morphology, and increased 
sweat gland density in east Asia (Fujimoto et al., 2008;Kamberov et al., 2013;Kimura et al., 
2009;Mou et al., 2008). 
1.3.5  Expression of Eda pathway components   
Prior to placode induction Eda and Edar are co-expressed in the ectoderm. Upon placode 
formation, Edar expression becomes strictly localized to the emerging primordia whereas 
Eda has been detected as a broader signal in the adjacent epithelium. During salivary gland 
development, prominent Eda expression has instead been found in the mesenchyme (Häärä et 
al., 2012;Headon and Overbeek, 1999;Laurikkala et al., 2001;Tucker et al., 2000). As development 
progresses, the expression of these genes eventually overlapps in certain parts of hair follicles 
(Laurikkala et al., 2002;Pispa et al., 2008). In developing mammary rudiments, Edar is found 
in the mammary epithelium, which is also characterized by high NF-κB activity (Bhakar et al., 
2002;Pispa et al., 2003;Pispa et al., 2008). Yet, the expression of Eda in a mammary gland context 
has not previously been described. 
In vitro evidence suggests that Eda is induced by the Wnt pathway (Laurikkala et al., 2002). 
To support this, Eda is downregulated in Lef1 defi cient mice and an active Lef1 binding site has 
been located in the Eda promoter (Durmowicz et al., 2002;Laurikkala et al., 2002). Moreover 
Edar expression is likewise upregulated by Wnt/β-cat and according to in vitro studies also by 
Activin. Previous studies have also shown Edar to be positively regulated by its own expression 
whereas Bmp4 signalling downregulates the receptor in the interplacodal area thus restricting 
Edar expression to the placodes. (Laurikkala et al., 2002;Mou et al., 2006;Zhang et al., 2009). 
1.3.6  Molecular targets of Eda 
Over the years, putative Eda/NF-κB target genes have been uncovered by candidate gene 
approaches (Mou et al., 2006;Pummila et al., 2007). Genome-wide approaches have compared 
transcriptomes of wild type and Eda gain and loss-of-function mice (Cui et al., 2002;Cui et al., 
2006) and more recently, embryonic Eda −/− skin exposed to recombinant Eda protein (Fliniaux 
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in hair and teeth. Th erefore many transcriptional targets have been identifi ed in these organs, 
whereas the genes mediating Eda signalling in other organs such as mammary glands remain 
largely unknown. As several signalling pathways are shared between diff erent ectodermal organs, 
it would however be expected that Eda target genes are also shared at least to some extent, though 
organ-specifi c diff erences are bound to exist.  
To date, the Eda pathway has been shown to interact with multiple major pathways involved 
in morphogenesis. For instance, Eda controls a group of Wnt pathway genes. Agonists Wnt10a, 
Wnt10b (Lefebvre et al., 2012;Zhang et al., 2009) and antagonist Dkk4 (Fliniaux et al., 2008), 
are upregulated by Eda in hair placodes. In addition expressions of Shh, Ctgf (connective tissue 
growth factor), Follistatin (Pummila et al., 2007), several chemokines (Lefebvre et al., 2012), Fgf20 
(Huh et al., 2013), Foxi3 (Shirokova et al., 2013) and Edar (Mou et al., 2006) are modulated by 
Eda signalling during hair development. Fgf20 is additionally induced by Eda in salivary glands 
(Häärä et al., 2012) and Foxi3 in numerous other foetal skin appendages (Shirokova et al., 2013).
1.4  Mammary gland development
Mammary glands are the most characteristic feature of all mammals. Although the detailed 
structure, number and location vary between species (Bateson, 1894), they are always composed 
of a branched epithelial ductal tree and mesenchymal stroma. Th e stroma that comprises 
mainly adipose tissue, fi broblasts and a lesser amount of other cell types supports the organ’s 
proper development and maintains it throughout life. Th e successful growth and function of 
the mammary glands is vital for the survival of off spring since the secreted milk is the main 
nutritional source of a new-born. Moreover, the produced milk strengthens the infant’s immune 
system by providing factors such as immunoglobulins and antibodies. Beyond its primary 
function, nursing of the young is believed to promote an emotional bond between mother and 
off spring (Anderson et al., 2007;Koyama et al., 2013;Propper et al., 2013).
Mammary glands are a late evolutionary novelty. Mammary glands are initially thought 
to have arisen from glandular structures that resembled enlarged sebaceous glands. It has been 
speculated that they were originally used by the fully terrestrial predecessors of mammals to 
secrete moisture which protected their parchment-shelled eggs from drying (Howard and Lu, 
2014;Oft edal and Dhouailly, 2013).
Mammary gland development can be divided in three distinct growth phases. Th e 
embryonic development is characterized by the formation of a species-typical number of 
mammary primordia and the onset of branching morphogenesis. Th e majority of the ductal 
growth and branching occurs during adolescence as the circulating ovarian hormones induce 
exponential branching of the rudimentary ductal tree. Th e most profound transition occurs 
during pregnancy and onset of lactation when hormonal cues guide the mammary gland to 
mature to its functional form (Cowin and Wysolmerski, 2010;Watson and Khaled, 2008).
1.4.1  Morphological development
From milk line to placode
Th e murine mammary gland development begins approximately at embryonic day E10.5 with 
the bilateral formation of milk lines (Figure 2) (Propper et al., 2013). Milk lines, however, are not 
visible to the naked eye but only obvious from histological sections or by molecular detection of 
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stripes that express Wnt10b arise at the ventrolateral border of the embryo, in the axillary and 
inguinal region and between the fore and hind limbs (Veltmaat et al., 2004).
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Figure 2. Position of milk lines and mammary rudiments in mice embryo.  
Th e milk lines form bilaterally on the ventrolateral borders of the fl anks (left ). Th e central streak 
( ) appears between the limbs whereas independent stripes form underneath the limbs (  ). 
Five mammary rudiments (mr1-mr5) emerge, on both fl anks of the embryo, three in the axial and two in 
the inguinal region (right); (dashed lines  indicate rudiments underneath the limbs).  
Milk lines have been described as morphologically elevated ridges in certain mammalian 
species such as the rabbit and human (Propper, 1978;Propper et al., 2013). Recently however, 
it was pointed out that the ridges found in rabbit may in fact refl ect a more advanced stage of 
development and not the onset of mammogenesis. Similarly to mouse, multilayering of the rabbit 
milk line precedes the elevation of the structures (Propper, 1978;Propper et al., 2013).      
By E11.5 fi ve pairs of mammary placodes, the number of glands in the adult animal, emerge 
symmetrically at conserved positions along the areas defi ned by milk lines (Figure 2 and 3). For 
the sake of clarity, in literature the mammary gland pairs are oft en numbered from one to fi ve, in 
rostro-caudal order (Biggs and Mikkola, 2014;Cowin and Wysolmerski, 2010). Placode pair one 
arises from the axillary milk line; numbers two, three and four from the milk line of the fl ank, 
and the inguinal streak gives rise to the fi ft h placode pair (Veltmaat et al., 2004). 
Even though diff erent mammary primordia come across as identical, the appearance of 
distinct placode pairs is asynchronous, independent from one another and does not occur in an 
anterior to posterior order typical to other repetitive structures of the body. Rudiment number 
three is the fi rst one to become visible and is soon followed by the fourth pair. Subsequently, pairs 
fi ve and one form approximately at the same time, and number two is the last one to emerge 
(Mailleux et al., 2002). 
From E11 to E14 the proliferative activity of the mammary epithelium is very low compared 
to the adjacent epidermis. Similar results have been obtained in mice and rabbits (Balinsky, 
mr1
mr2
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1950; Lee et al., 2011). In addition previous studies using a scanning electron microscopy have 
revealed that in rabbits some of the cells residing atop the milk line have characteristics typical 
for motile, migrating cells such as philopodia (Propper, 1978). Indeed, the formation of placodes 
is thought to rely on migration of mammary precursor cells along and from the surrounding 
area of the milk lines. Th e infl ux of cells towards the future placode sites is thus the main source 
of mammary epithelial growth together with the increase of individual cell volume within the 
primordia (Kogata et al., 2014;Lee et al., 2011). However, only live imaging of the milk line 
during placode formation will off er defi nite proof of the matter.
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Figure 3. Embryonic mammary gland development. 
Th e mammary rudiment development commences with the formation of milk lines at E10.5. By E11.5 
all fi ve pairs of mammary placodes have emerged. Th ey gradually develop from hillock to a bud which is 
surrounded by the primary mammary mesenchyme. Th e bulb elongates to a primary sprout that grows 
towards the fat pad precursor cells. By birth, a small ductal tree with several branches has formed.  
From bud to branching morphogenesis
Th e placode gradually transforms via hillock structure to a bud by E13 (Figure 3). By then, the 
mammary epithelium has grown downward and is surrounded by several layers of diff erentiated, 
condensed primary mammary mesenchyme. Further growth of the primordium gives rise to a 
bulb-like structure that is characterized by a narrow neck at E14 (Propper et al., 2013;Robinson 
et al., 1999). By E16.5 the tip of the primordium elongates to form a primary sprout, which 
invaginates through the dermis into the more distal secondary mammary mesenchyme or the fat 
pad precursor compartment. Th e fat pad precursor cells, together with the primary mammary 
mesenchyme, comprise the embryonic stroma that surrounds the mammary epithelium. 
Precursors of the fat pad, preadipocytes, are already present in the mouse embryo from E13.5 
onwards but they only mature to adipose tissue couple of days aft er birth (Sakakura et al., 1982). 
Th e fi rst branches begin to form from E16.5 onwards. Th e nipple sheath, thickening of the upper 
epithelium, which later on produces the nipple, appears at E17.5. Concurrently the ductal lumen 
formation commences with the appearance of small microlumens that progressively enlarge 
and join together (Hogg et al., 1983). By birth, approximately at E19, the lumen formation is 
complete, and a small ductal tree of 10-15 branches has developed.
Th e branching pattern of the mammary gland is stochastic. Th e precise number of ductal 
tips per time point is not predetermined and varies between mouse strains and even among 
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primordia of the same pair (Veltmaat 2003). Th e diff erent mammary gland pairs also develop 
at individual speeds. By birth, the second and the third rudiments exhibit a more extensive 
ductal network compared to the other glands. Th is supports the notion that mammary glands 
are not identical and that they utilize at least partly divergent mechanisms for their individual 
development and growth (Propper et al., 2013;Veltmaat et al., 2003).
  
Significance of mammary mesenchyme and microenvironment
Th e importance of the mammary mesenchyme is apparent as epithelial mammary primordia 
fail to develop in its absence (Kratochwil, 1969). Indeed, the instructive signal for organ 
induction appears to originate from the mesenchyme. Tissue recombination studies have 
further demonstrated that the mammary mesenchyme can direct the morphogenesis of 
various ectodermal structures and regions towards a composition typical for mammary glands. 
Th is instructive capacity is highly conserved even across diff erent species. Murine mammary 
mesenchyme is able to instruct the dorsal surface ectoderm of a rat embryo to form a mammary 
gland (Cunha et al., 1995). 
Once mammary epithelium is recombined with mesenchyme originating from salivary 
gland and grown under a kidney capsule, the mammary-like branch pattern is lost, and the 
craft ed organ resembles a salivary gland. Part of the mammary cell identity is retained, however, 
as the epithelium remains capable of producing proteins typical of milk composition in the 
correct hormonal environment. Th ese experiments demonstrate that mesenchymal cues control 
the pattern of branching though the mammary cell fate remains unaltered (Sakakura et al., 1976).
In mice the initial development of mammary glands proceeds identically in both male and 
female embryos. By E14.5, the secretion of testosterone from the male testis activates androgen 
receptors (AR) that are present in the condensed primary mammary mesenchyme. Th is triggers 
apoptosis in the mammary mesenchyme as well as in the epithelium, and as a consequence 
the connection between the bulb and the surface epidermis is eventually severed (Heuberger 
et al., 1982;Kratochwil and Schwartz, 1976). Th e remaining mammary epithelium regresses 
and disappears. Even though males of some strains may retain an extremely rudimentary 
ductal system in adulthood, in most cases the mammary glands and nipples do not form 
in males (Dunbar et al., 1998;Durnberger and Kratochwil, 1980;Kratochwil and Schwartz, 
1976;Kratochwil, 1977). However, in most other mammals, including human, the embryonic and 
prepubertal development are practically identical in both genders, and the sexual dimorphism of 
the glands does not occur until puberty.  
1.4.2  Molecular regulation of development
From the milk line to the placode
Th e molecular regulation of the milk line specifi cation and the placode induction has begun to 
receive more attention during the past decade. Substantial data have been gained by the study of 
diff erent mouse models where downregulation or loss-of-function of a gene leads to impaired 
milk line formation and/or the absence of particular placode pairs (Table1.). Especially Fgf10, 
Nrg3, canonical Wnt signalling and transcription factors Gli3 and Tbx3 are necessary during 
the initial stages of mammogenesis (Cowin and Wysolmerski, 2010). Transcription factor p63 is 
also required for the commitment of the surface ectoderm to epidermal fate and induction of all 
ectodermal appendages, including mammary placodes (Mills et al., 1999).
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Fgf10 is one of the earliest genes known to be essential for the specifi cation of the milk 
line. Fgf10 is expressed as a gradient from the ventral tips of the extended thoraric somites at 
E10.25. Its signalling partner, Fgf2rb, has been localized to the surface ectoderm and later to 
the emerging placodes (Mailleux et al., 2002;Veltmaat et al., 2006). In the absence of Fgf10 or 
Fgf2rb, milk line formation becomes impaired and only placode four is able to develop (Mailleux 
et al., 2002;Veltmaat et al., 2006). The signifi cance of somitic Fgf10 in milk line positioning is 
further evidenced by the dorsalisation of the milk line in mutants where the ventral extension of 
the somites is undeveloped (Veltmaat et al., 2006). For mammary placodes one and fi ve that are 
not located in close vicinity of the dermomyotomes, the signalling source of Fgf10 most likely 
is the adjacent limb bud mesenchyme (Veltmaat et al., 2006;Xu et al., 1998). 
Expression of Gli3 is found in the somites concurrently with Fgf10. Its actions appear to 
partly regulate Fgf10 as loss of Gli3 leads to downregulation of Fgf10. Attenuation of Fgf10 has 
been proposed to be the reason behind the failure of placodes three and fi ve to form in Gli3 null 
and Fgf10 hypomorph mice (Veltmaat et al., 2006). Positive Hedgehog signalling is necessary 
for the development of many ectodermal organs. In mammary glands, however, Gli3 functions 
as a repressor of the Hedgehog pathway (Hatsell and Cowin, 2006). How the Gli3 repressor 
regulates Fgf10 expression is not understood.  
Tbx3 is fi rst detected at E10.25 as a continuous streak in the mesenchyme of the presumptive 
milk line region. The expression shifts to the ectoderm prior to placode formation and fi nally 
accumulates in the emerging epithelial rudiments by E11.5. Mice deprived of Tbx3 occasionally 
develop mammary placode number two, whereas other placodes are always lost (Davenport et 
al., 2003). Expression of a closely related member, Tbx2, is likewise found in the mammary 
mesenchyme at the onset of placode formation. However, the absence of Tbx2 has no effect 
on mammary placode induction (Jerome-Majewska et al., 2005). In humans, haploinsuffi ciency 
of TBX3 results in ulnar-mammary syndrome which is characterized by severe mammary 
hypoplasia (Bamshad et al., 1997).
Tbx3 has been proposed to act both up- and downstream of Fgf and Wnt pathways (Chu 
et al., 2004;Eblaghie et al., 2004). During placode formation Tbx3 is required for the localized 
expression of Wnt10b and Lef1 in the mammary epithelium and in vitro studies have further 
demonstrated that Tbx3 potentiates Wnt and Fgf signalling (Davenport et al., 2003;Eblaghie et 
al., 2004). Experimental manipulations have also shown that on the ventral side of the embryo 
Tbx3 is antagonized by Bmp4. The opposing effects of the genes are believed to position the 
future milk line to the dorso-ventral border of the embryo by regulation and maintenance of 
positive Wnt activity (Cho et al., 2006). Gli3 appears to control Tbx3/Bmp4 patterning within 
the region of placode number three. In the absence of Gli3, Bmp4 expression pattern broadens, 
which most likely in turn inhibits Tbx3 (Chandramouli et al., 2013). Recent in vitro studies 
have also suggested that retinoic acid (RA) signalling induces or maintains Tbx3 expression. 
Curiously, the receptor for RA is co-localized with Fgf10 in the dermomyotomes of the somites, 
which might indicate a role in mammary placode induction and possible interactions with Fgf10/
Fgfr2b signalling (Cho et al., 2012).    
Another important molecule for embryonic mammary gland development is Nrg3 that is 
fi rst observed prior to placode formation in the dermal mesenchyme. The expression switches 
to epithelial compartment as placodes mature (Wansbury et al., 2008). Placode pair three is 
especially sensitive to impaired Nrg3 signalling, as it is frequently absent or surrounded by 
ectopic placode-like structures in the hypomorphic Nrg3 mutants (Scaramanga mutants) 
(Howard et al., 2005). Fgf10 and Tbx3 expression remains unaltered in the Scaramanga, which 
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places Nrg3 either downstream of the factors or indicates independent, parallel signalling. Ex 
vivo application of Nrg3 induces Wnt signalling and formation of placode-like structures that 
express Lef1 (Howard et al., 2005). Gain-of-function K14-Nrg3 mice on the other hand develop 
ectopic mammary glands, which further supports the role of Nrg3 in mammary induction and 
promotion of mammary cell fate (Panchal et al., 2007).
Th e milk line was originally identifi ed by low-level tripartite expression of Wnt10b at E10.5 
(Veltmaat et al., 2004). As placodes emerge, the expression transiently connects all independent 
milk lines of a fl ank, whereas the placodes exhibit higher Wnt10b levels. Additionally, Wnt6 and 
Wnt3 are expressed prior to placode formation along the milk line in a broader pattern together 
with mesenchymal Wnt5a and Wnt11 (Chu et al., 2004). Lef1 is expressed at the onset of placode 
development, and as the placodes mature, it gradually becomes confi ned to the emerging 
epithelial structures and to the surrounding mesenchyme (Boras-Granic et al., 2006). Only three 
placode pairs develop in Lef1−/− embryos, and they eventually regress (van Genderen et al., 1994).
Overexpression of Wnt inhibitor Dkk1 in the surface epithelium abolishes induction of 
all mammary primordia, which further underlines the necessity for proper Wnt signalling. 
Dkk1 expression, however, does not alter Fgf10 expression. Th is places Wnts downstream or 
independent of Gli3-Fgf10-Fgfr2b signalling (Chu et al., 2004). In line with this, TopGal and 
Wnt10b expression is not found in Fgf10 hypomorph embryos or Gli3 mutants (Veltmaat et al., 
2006). 
Ex vivo application of Wnt3a increases the placode size and artifi cial activation of the 
pathway with LiCl induces formation of ectopic placode-like structures along the fl ank (Chu 
2004). In vivo loss of Sostdc1 function, a potent inhibitor of Wnt signalling, or its receptor Lrp4 
causes upregulation of β-cat along the milk line, which most likely is the explanation for the 
ectopic nipple structures found in the adult females (Ahn et al., 2013;Närhi et al., 2012). 
From bud to ductal tree  
Transcription factors Msx1 and Msx2 are localized to the mammary epithelium and Msx2 
additionally to the surrounding mesenchyme of the bud. Whereas the loss of only one factor 
has no drastic eff ect on bud formation, the disruption of both genes leads to unusually small 
placodes that do not develop beyond the bud stage (Satokata et al., 2000). In addition, Msx2−/− 
mice display a delayed branching morphogenesis that is, however, normalized soon aft er birth 
(Hens et al., 2007). 
Pthrp is expressed from the placode stage onwards in the mammary epithelium, whereas its 
receptor, Pthr1, is located in the surrounding mesenchyme (Dunbar et al., 1998). Th e mammary 
primordia of Pthrp−/− embryos develop normally until the late bulb stage. However, the lack of 
Pthrp signalling disrupts the development of the primary mammary mesenchyme, and, as a 
result, initiation of ductal morphogenesis never occurs and the bulb reverts back to epidermal 
fate (Wysolmerski et al., 1998). Pthrp null embryos display severely reduced or completely 
abolished expressions of Tenascin-c, oestrogen receptor α (ERα) and AR in the primary 
mammary mesenchyme (Dunbar et al., 1999). Pthrp has also been shown to be responsible for 
mesenchymal Wnt activity and expression of lef1 and β-cat, which are thought to mediate the 
specifi cation of the mammary mesenchyme (Hiremath et al., 2012). Th e lack of mesenchymal 
AR in the Pthrp null embryos leads to a loss of sexual dimorphism as the androgen-induced 
destruction of the mammary bulbs does not take place (Dunbar et al., 1999).
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During normal rudiment growth, Pthrp enhances the Bmp1 receptor gene expression 
in the mesenchyme and thereby sensitises it to concurrently-expressed ligand Bmp4. Tissue 
culture experiments have demonstrated that application of Bmp4 can overcome the stunted 
bulb phenotype, indicating that it is an important downstream eff ector of Pthrp (Hens et al., 
2007). Bmp signalling in turn has been shown to activate several factors important for further 
development (Hens et al., 2009).  
In addition, Pthrp is important for nipple formation. Th e mammary mesenchyme instructs 
the keratinocytes of the proximal part of the mammary sprout to form a nipple sheath that 
later on develops into a nipple. Mesenchymal Msx2, which is induced by Pthrp, suppresses hair 
placode formation in the immediate surroundings of the future nipple. Expression of Pthrp 
throughout the basal layer of the skin under the K14-promoter redirects the entire ventral 
epithelium to adopt hairless nipple tissue fate (Foley et al., 2001;Hens et al., 2007). 
Th e importance of Wnt signalling is not restricted to the early stages of mammogenesis 
(Incassati et al., 2010); rather it continues to play a role in the further development of the 
rudiments (Boras-Granic et al., 2006;Chu et al., 2004;Lindvall et al., 2006;Lindvall et al., 2009). 
Th e disruption of diff erent pathway components leads to abnormal Wnt activity, which translates 
into impaired ductal development. Lrp5 and Lrp6 loss-of-function embryos exhibit decreased 
Wnt activity and abnormally small mammary placodes/buds. Th e subsequent outgrowth of the 
organ is delayed but otherwise normal in Lrp5 mutants, whereas Lrp6−/−embryos display a stunted 
branching morphogenesis and reduction in the size of the fat pad prior. Whether the observed 
phenotype of the mice is a result of epithelial or mesenchymal defects is not clear (Lindvall et al., 
2006;Lindvall et al., 2009). Lack of Pygo2, a downstream component of Wnt signalling, leads to a 
similar phenotype with impaired mammary bulb growth and stagnant branching morphogenesis 
(Gu et al., 2009).
Fairly little is known about fat pad development, considering its immense importance for 
sustaining mammary gland formation and growth. Fat pad development requires Lef1, as the 
structures are unusually small in loss-of-function mutants (Boras-Granic et al., 2006). During 
late embryogenesis, expression of Fgf10 has been localized to fat pad precursor cells, and the 
compartment is underdeveloped in Fgf10−/− embryos. Th e only epithelial rudiment pair that 
manages to form in the mutant embryos displays impaired branching morphogenesis. However, 
the ductal development can be rescued by transferring the rudiment to wild type stroma, which 
indicates that the observed phenotype is due to Fgf10-defi cient fat pad (Mailleux et al., 2002). 
However, as Fgf10 signals via epithelial Fgfrs, the eff ect on the fat pad is likely indirect. 
In addition to its early inductive role in mammogenesis, Gli3 is necessary for the later 
stages of development. Gli3 is required by primordia number two that fails to form a primary 
sprout or initiate branching morphogenesis and instead protrudes outward from the skin in Gli3 
null mutants (Chandramouli et al., 2013;Lee et al., 2011). Th e mice also fail to maintain proper 
mammary mesenchyme identity and exhibit downregulation of typical mesenchymal markers 
including AR. Scarcity of AR expression suppresses apoptotic destruction of the male mammary 
rudiment (Chandramouli et al., 2013).
Hoxc6 loss-of-function halts the ductal development of the thoracic primordia to the 
primary sprout stage and impairs the fat pad development (Garcia-Gasca and Spyropoulos, 
2000). However, the signalling networks involved are unknown. 
Finally, defi ciency of the epidermal growth factor receptor (Egfr) diminishes branching 
morphogenesis but does not otherwise impair the embryonic sprouting or ductal development. 
Protease Adam17 is required to release Egfr ligand Areg from the cell surface. Adam17 −/−
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neonates display an identical undeveloped ductal phenotype as Egfr−/− animals, which indicates 
that Areg is an important factor in the early ductal development (Sternlicht et al., 2005) (Table1.). 
Table 1. Selected mouse models that exhibit abnormal embryonic mammary gland phenotype. 
MP=mammary placode; MR=mammary rudiment.
Mouse model Phenotype Reference
Altered placode induction
p63-/- No placodes (Mills et al., 1999)
Fgf10-/- Present: MP4 (Mailleux et al., 2002)
Fgfr2b-/- Present: MP4 (Mailleux et al., 2002)
Gli3-/- Present: MP1, 2, 4 (Hatsell and Cowin, 2006)
Tbx3-/- Occasionally present: MP3 (Davenport et al., 2003)
K14-Dkk1 No placodes (Chu et al., 2004)
Lef1 -/- Present: MP1, 4, 5. Degenerate later. (van Genderen et al., 1994)
Pygo2-/- Small placodes/ buds (Gu et al., 2009)
Lrp5-/- or Lrp6-/- Small placodes/buds (Lindvall et al., 2009)
Ska (Nrg3 hypomorph) Occasionally ectopic MP around MP4 (Howard et al., 2005)
K14-Nrg3 Ectopic placodes (Panchal et al., 2007)
Lrp4-/- Ectopic placodes (Ahn et al., 2013)
K14-Eda Ectopic placodes (Mustonen et al., 2003; 
Mustonen et al., 2004)
Altered morphogenesis aft er placode induction
Msx2-/- Arrest at sprout stage/delayed branch-
ing
(Satokata et al., 2000)
Msx1-/-;Msx2-/- Stunted branching (Satokata et al., 2000)
PTHrP-/- or Ptr1-/- Arrest at bud stage (Foley et al., 2001)
Gli3-/- Stunted branching of MR2 (Chandramouli et al., 
2013;Lee et al., 2011) 
Fgf10-/- Stunted branching of MR4 (Mailleux et al., 2002)
Areg-/- Delayed branching (Sternlicht et al., 2005)
Adam 17-/- Delayed branching (Sternlicht et al., 2005)
1.4.3  Postnatal development
Between birth and puberty the size of the mammary gland does not alter greatly. Growth of the 
organ is isometric,  in other words it maintains but does not exceed the rate at which the animal 
increases body mass. Whereas the embryonic mammary gland has multiple layers of epithelial 
cells, the ducts of a postnatal gland are bilayered and contain two distinct cell populations; the 
outer basal or myoepithelial and inner luminal cells (Sternlicht et al., 2006). Th e embryonic 
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and prepubertal phases of the mammary gland morphogenesis is hormone-independent. Th e 
rudiments form normally in oestrogen, prolactin, progesterone and growth hormone receptor 
knock-out mice. However, all these factors are a necessity during the following, hormone-
dependent, development (Bocchinfuso et al., 2000;Curtis Hewitt et al., 2000;Macias and Hinck, 
2012).
At puberty, the morphology of the gland begins to change drastically as extensive ductal 
elongation and branching takes place. Bulbous, highly proliferative and multicellular terminal 
end bud (TEB) structures appear to the distal tips of the gland. Bifurcation of the TEBs creates 
new primary branches, whereas secondary branches sprout laterally from the trailing ducts. By 
week 12, the TEBs have reached the far ends of the fat pad and regress to terminal ducts. At this 
stage the elaborate ductal network fi lls a large portion of the fat pad. A recurrent oestrous cycle 
remodels the gland by producing transient tertiary branches off  the secondary ducts (Sternlicht 
et al., 2006). 
During pregnancy, the mammary gland undergoes further maturation to prepare for 
lactation. Widespread tertiary branching commences during early pregnancy and fi lls the 
majority of the empty space between the ducts. Th e tips of the newly-formed branches 
diff erentiate progressively into secretory alveolar cells that give rise to the milk-producing 
lobules of the lactating gland. Weaning initiates involution, another massive remodelling of the 
mammary epithelium. Th e obsolete milk-producing alveolar structures are removed from the 
gland either by apoptosis or by transdiff erentiation to other cell types, and the gland reverts close 
to a state prior to pregnancy. Th e same cycle repeats with each pregnancy (Brisken and O’Malley, 
2010;Sternlicht et al., 2006). 
Morphogenesis aft er the onset of puberty depends on oestrogen, growth hormone, 
progesterone and prolactin. Th e mammary-gland-typical responses to hormonal signalling are 
mediated by specifi c hormone receptors located in the mammary epithelium and the stroma. 
Adolescent ductal development depends on oestrogen and growth hormone. Th e absence of 
oestrogen receptor alpha inhibits the formation of TEBs, which in turn impairs invasion of 
the epithelial ducts to the fat pad (Mallepell et al., 2006). Th e lack of growth hormone receptor 
induces highly similar defects in adolescent mice (Gallego et al., 2001). Pregnancy-induced 
side branching depends instead on progesterone, as the structures do not form in females 
with defi cient progesterone receptors. Progesterone also controls alveologenesis together with 
prolactin (Brisken et al., 1998;Ormandy et al., 1997). Th e systemic hormonal cues are eventually 
translated to local paracrine messages that mediate their eff ects with distinct factors. Th e full 
scale of hormone interaction with developmental signalling pathways in mammary gland 
branching morphogenesis and diff erentiation is still being discovered. 
Of the developmental pathways that are employed in embryonic mammogenesis, many 
are also active during hormone-dependent stages. Areg is an essential mediator of oestrogen-
induced proliferation during puberty (Ciarloni et al., 2007), whereas growth hormone is believed 
to act mainly through Insulin-like growth factor 1 (Igf1) (Kleinberg et al., 2000). Furthermore, 
Fgfr2b is required for TEB maintenance (Lu et al., 2008;Parsa et al., 2008) and Fgf10 has been 
shown to regulate branch initiation (Zhang et al., 2014). Th ough loss of Wnt5a does not alter 
embryonic mammary gland induction (Chu et al., 2004), it accelerates and enhances ductal 
growth during hormonal development by increasing lateral branching and TEB size (Roarty and 
Serra, 2007). R-spondin1 was recently shown to mediate hormone action and to be upregulated 
during diff erent stages of pregnancy (Cai et al., 2014). In addition, Wnt4 and Tnf family member 
RANKL and have been identifi ed as a progesterone target genes (Beleut et al., 2010;Brisken et al., 
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2000;Mulac-Jericevic et al., 2003). NF-κB on the other hand has been recognized as a positive 
regulator of ductal growth during adolescence and pregnancy (Brantley et al., 2000;Cao and 
Karin, 2003). 
 
1.5  Variations in mammary gland number  
Th e number and location of the mammary glands present in adult animals vary widely between 
diff erent mammalian species. Humans and other primates have one thoracic pair, whereas 
ungulates such as goats, sheep and horses have their only pair located in the inguinal part of 
the ventral body. Similarly, whales have only one mammary gland pair which is located near 
the genitalia and manatees have one nipple in each armpit (Rodrigues et al., 2014). Several 
animals also exhibit multiple pairs of mammary glands. Domesticated pigs for instance can have 
as many as nine sets of glands that run from the axilla towards the groin. Th e teat number in 
pigs is a variable trait and is commonly used as an indicator of reproductive performance (Xu 
et al., 2014). Th ough the regular house mouse (Mus musculus) has its fi ve mammary gland pairs 
distributed in both the upper torso and groin region, other rodent species display much more 
variation in the number of glands (Gilbert, 1986). Th e most extreme case is the multimammate 
mouse (African soft  furred rat) of Mastomus genus that can have up to 12 equally-spaced nipple 
sets located throughout the ventral region from axilla to groin (Brambell et al., 1941).  
Th e number of glands correlates closely with the amount of off spring typically birthed at 
a time. Most commonly the litter size is one half of the gland number and rarely exceeds their 
amount (Bresslau, 1920;Diamond, 1987;Gilbert, 1986;Sherman et al., 1999). With only a few 
exceptions, the organs are located symmetrically along the anterior-posterior axis, and they form 
in conserved positions within a species (Koyama et al., 2013;Sherman et al., 1999).
1.5.1  Supernumerary mammary glands in humans
In humans, supernumerary nipples or polythelia are fairly typical developmental abnormalities 
with prevalence ranging from 0.2% to 5.6% (Ferrara et al., 2009). Th e number of the accessory 
nipples is not constant and can vary from one to even seven (Goyal et al., 2012). Th ese structures 
are occasionally associated with breast tissue (polymastia) and have been described frequently 
over the past few centuries in both genders (Kajava, 1915;Loukas et al., 2007;Velanovich, 
1995;Williams, 1891). Oft en additional nipples and associated glandular tissue are very 
rudimentary compared to endogenous breasts though they appear to respond to hormonal 
stimulation and undergo physiological changes similarly. Ectopic nipples can for instance secrete 
milk, and the glands are oft en reported to increase in size during pregnancy (Williams, 1891).
Accessory nipples generally form within the area defi ned by the embryonic milk lines 
which extend from the armpit to the pubic region. On occasion, ectopic nipples have also been 
described in unusual locations, such as the face and the sole of the foot (Balakrishnan and 
Madaree, 2010;Conde et al., 2006). Most oft en polythelia arises as a sporadic phenomenon. 
However, it can also be inherited as a solitary trait or as familial aggregation, where polythelia is 
one of several other defects that manifest within a family. Kidney and urinary tract abnormalities 
are the most frequent associations with supernumerary nipples (Ferrara et al., 2009). Genetic 
disorders such as Simpson–Golabi–Behmel syndrome have occasionally been described with 
supernumerary nipples (Neri et al., 1998).
Ectopic nipples are not restricted to humans but are also reported in other primates (Hsu et 
al., 2000). Supernumerary teats are likewise a frequent abnormality of the bovine udder (Giff ord, 
1934;Pausch et al., 2012). 
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1.6  Relevance of embryonic mammary gland development to 
breast cancer
Breast cancer is a highly heterogenous disease that can arise in various parts of the mammary 
gland such as epithelial ducts, milk producing lobules and the mesenchymal stroma. On average 
every 8th woman is aff ected by breast cancer during her lifetime, although factors such as ethnic 
origin, lifestyle, environment, family and reproductive history can have an impact on the 
occurrence. Breast cancer is not restricted to women but also aff ects men, though the number of 
incidences is fairly small (http://www.cancer.org/cancer/breastcancer). Similarly, ectopic breast 
tissue that is occasionally associated with supernumerary nipples is susceptible to oncogenesis 
with low frequency (Francone et al., 2013).
Th e manner in which the embryonic mammary glands form manifests parallel 
characteristics to certain features typical to breast cancer (Howard and Ashworth, 2006). During 
embryogenesis, processes that are required for mammary gland development, such as cell 
migration, proliferation, diff erentiation and ductal invasion to the surrounding mesenchyme, 
occur in a tightly controlled and coordinated manner. Cancerous cells utilize similar mechanisms 
for growth and metastasis, invasion of the cancer cells to other parts of the body. Many of 
the signalling pathways that are needed for ordinary mammogenesis become misregulated in 
breast cancer. Transcription factor Tbx3 has for example been associated with breast cancer 
(Douglas and Papaioannou, 2013). Similarly, breast cancer cells have oft en been found to possess 
constitutively activated NF-κB (Shostak and Chariot, 2011;Sovak et al., 1997). ErbB4, receptor 
for Nrg3, on the other hand can heterodimerize with ErbB2, which has a profound link to breast 
cancer (Holbro et al., 2003). Several studies have also implicated Pthrp and Wnts in breast cancer 
and metastasis (Boras-Granic and Wysolmerski, 2012;Howard and Ashworth, 2006).
Induction and growth of the epithelial mammary rudiment relies on mesenchymal 
signalling. During postnatal life, the mammary stroma supports and maintains the development 
of the gland. Tissue recombination experiments have shown that the combination of epithelial 
mammary tissue with the embryonic primary mammary mesenchyme results in a hyperbranched 
ductal phenotype, whereas growth with the fat pad gives rise to a gland that has undergone 
regular branching morphogenesis (Sakakura et al., 1987). Th e tumour microenvironment might 
resemble the embryonic mammary mesenchyme in this regard, and exposure of the epithelial 
structures to such conditions might promote initiation and progression of breast cancer 
(Sakakura et al., 2013). Research on tumour microenvironment has become a topic of greater 
interest in recent years.
Th us, understanding the normal developmental processes and how diff erent signalling 
pathways contribute to morphological changes and modulate each other’s function may help to 
understand the processes that are responsible for breast cancer. Targeted modulation of certain 
signalling pathways or utilizing their innate feedback mechanisms has indeed been exploited in 
cancer therapies and drug discovery (Curtin and Lorenzi, 2010;Howard and Lu, 2014).
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2 Aims of the study
Th e absence of Eda impairs the morphogenesis of many epithelial appendages, but prior to this 
work, relatively little was known about Eda’s function in mammary gland development. Previous 
reports had indicated that an excess of Eda stimulates ectodermal organ development. Strikingly, 
overexpression of Eda had been shown to induce formation of supernumerary mammary 
placodes within the milk line (Mustonen et al., 2003;Mustonen et al., 2004) suggesting the 
involvement of Eda also in mammogenesis. Most Eda downstream eff ectors had been identifi ed 
in organs such as teeth and hair, yet the downstream pathways and target genes of Eda in 
mammary glands were unknown.
Th e aims of the thesis are as follows:
1)  To characterize Eda gain- and loss-of-function mammary primordia phenotypes during 
several stages of prepubertal mammary gland morphogenesis.
2)  To study the relevance of transcription factor NF-κB in mammogenesis during prepubertal 
development and to assess its possible signifi cance as a downstream mediator of Eda.
3)  To identify and validate potent Eda downstream targets in mammary primordia.
4)  To develop ex vivo culture methods for studying embryonic mammary gland development, 
which can be utilized to evaluate the eff ects of individual Eda downstream eff ectors on 
placode formation and branching morphogenesis.
Aims of the study
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3  Materials and methods
In my thesis work, the mouse was used as a model organism. TopGal and BatGal reporter mice 
were used to determine activity of Wnt signalling and NF-κB reporter strain to observe NF-κB 
activity. Eda gain- and loss-of-function mice (K14-Eda and Eda −/−) were utilised to elucidate 
the role of Eda in mammary gland development and IκBαΔN mouse line to study importance 
of transcription factor NF-κB. Th e mice strains were maintained in NMRI, C57BL/6, FVB or 
B6CBA background.  
   
Mouse strain        Reference Used in article
NMRI              Jackson Laboratories I, II, III
C57BL/6        Harlan I, II, III
B6CBA        Harlan III
FVB              Harlan III
TopGal         (DasGupta and Fuchs, 1999) II, III
BatGal         (Maretto et al., 2003) III
NF-κB  gal        (Bhakar et al., 2002) II,III
K14-Eda         (Mustonen et al., 2003) I, II, III
Eda−/− (Tabby) Harlan II, III
IκBαΔN     (Schmidt-Ullrich et al., 2001) II, III
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Methods that were used in this thesis work are described in detail in the original articles and the 
manuscript. Tissue culture of embryonic mammary rudiments was an essential part of observing 
branching morphogenesis and placode formation and is discussed more thoroughly in the results 
and discussion section.  
Method Used in article
Immunological detection of proteins  
Immunohistochemistry II, III
Immunofl uorescence III
Gene expression analysis    
Whole-mount in situ hybridization I, II, III
Non-radioactive in situ hybridisation on sections II, III
Radioactive in situ hybridisation on sections II, III
Quantitative RT-PCR II, III
Aff ymetrix Mouse Exon 1.0 ST microarray II
Microscopy    
Bright fi eld microscopy I, II, III
Fluorescent microscopy II, III
Confocal microscopy   III
Scanning electron microscopy II
Tissue culture   I, II, III
mammary rudiment branching morphogenesis I, III
mammary placode formation II
Others      
Histology II, III
Carmine alum staining of mammary glands I, II, III
X-gal staining II, III
Cell proliferation assay (EdU) III
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Analysis of gene expression pattern by radioactive in situ hybridization was done by using 35S-
UTP labelled probes and non-radioactive in situ hybridization was done by using digoxigenin 
labelled probes. In the following table the probes are listed and their original references are 
indicated. 
Probes  Reference Used in article
Lgr4 article II II
Kremen2 article II   II
Dkk4 (Fliniaux et al., 2008) II
Lef1 (Travis et al., 1991) II
Wnt10a (Dassule and McMahon, 1998) II
Wnt10b (Wang and Shackleford, 1996) II, III
β-cat (Laurikkala et al., 2002) II
Shh (Vaahtokari et al., 1996) II
Pthrp article III II, III
Nrg3 (Howard et al., 2005) II
Tbx3 (Howard et al., 2005) II
Mmp9 article II   II
Adamts-15 article II II
Edar        (Laurikkala et al., 2001) II, III
Eda        (Laurikkala et al., 2001) II, III
Areg article III   III
Epgn article III III
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4  Results and discussion
4.1 Ex vivo culture of mammary primordia (I, II, III)
Embryonic explant cultures sustain tissue and its normal interactions in a closed, artifi cial system 
that allows the monitoring and precise manipulation of morphogenesis. To date, embryonic 
mammary glands have not been studied as thoroughly as some ectodermal organs, such as hair, 
teeth and salivary glands, or other branched organs such as lungs and kidneys. As a result, very 
few articles have described techniques for culturing the embryonic mammary glands. Instead, 
much of the research has focused on adolescent or pregnancy-induced epithelial morphogenesis. 
For example, the mammosphere assays and the transplantation of epithelial cells to cleared 
fat pads are frequently used, well-established methods for assessing stem cell/progenitor cell 
activities and hormone-dependent morphogenesis (Brill et al., 2008;Shaw et al., 2012). Th ree-
dimensional mammary organoid cultures consisting of isolated pieces of epithelial ducts, 
have been adopted to assess and image various aspects of mammary epithelial cell behaviours 
including branching morphogenesis (Ewald, 2013;Shamir and Ewald, 2014), but these culture 
systems lack the normal epithelial-mesenchymal tissue interactions known to be critical for 
mammary gland development. In order to study mammary placode induction and branching 
morphogenesis we developed two ex vivo culture systems. 
Previously, formation of mammary placodes has been assessed by culturing E10.5 to 
E11.5 stage embryos that have been sagitally dissected into two symmetric halves (Chu et al., 
2004;Kogata et al., 2013). Accordingly, I cultured E10.5 to E11.5 explants in a Trowell-type 
setup, a well-established technique, where tissues are kept at the gas-medium interface on 
top of a thin membrane that is supported by a metal grid (Närhi and Th esleff , 2010;Sahlberg 
et al., 2002;Trowell, 1959). I utilised control and K14-Eda embryos expressing the K17-GFP 
transgene (Bianchi et al., 2005) that marks the forming mammary placodes and monitored the 
development for 2-3 days. Although the endogenous primordia emerged under these culture 
conditions within two days in both genotypes, the ectopic placodes of K14-Eda embryos were 
not able to develop (Figure 4). 
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Figure 4. K17-GFP half embryo cultures. 
K17-GFP half embryos were cultured from E10.5 onwards. During the culture period mammary 
placodes 3 and 4 emerged on the fl ank. However culture of K14-Eda embryos did not yield formation 
of the supernumerary placodes (not shown). Dashed line marks the milk line region, FL=fore limb, 
HL=hind limb, arrowheads point to the emerging mammary primordia. (Scale bar: 500 μm)
E10.5+0d E10.5+1d E10.5+2d
FL
HL
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Overexpression of Eda is evident in the ectoderm already at E10.5 onwards (Mustonen et al., 
2003), yet the supernumerary mammary placodes do not form until E12.5 to E13. Th e delayed 
development of the ectopic mammary placodes is the likely explanation to why I could not 
observe them in the explant cultures initiated already at E10.5 or E11.5. For this reason, I next 
cultured E12.5 fl ank skins, which comprised epithelial and mesenchymal compartments of the 
mammary forming region. In the explants, the endogenous mammary placodes had already 
formed, whereas the rest of the milk line region remained undeveloped. Aft er two days of culture 
(E12.5+2d) the K14-Eda explants had developed placode-like structures between the third 
and the fourth mammary bud whereas the wild type explants displayed no such composition. 
Commonly, formation of two to three supernumerary primordia were observed, which 
corresponded to the adult phenotype of K14-Eda mice. Application of Fc-Eda uncovered the 
same mammary forming potential of the milk line. When wild type fl ank skins were cultured 
for two days (E12.5+2d) in the presence of the recombinant protein, mammary placode-like 
structures appeared in the fl ank. Th ese results indicate that the application of Fc-Eda to wild type 
skins recapitulates the K14-Eda phenotype (Figure 5).
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Figure 5. Ex vivo culture of E12.5 mammary forming region. 
In wild type explants the fi ve endogenous mammary buds are present.  Supernumerary mammary 
placodes (*) form in K14-Eda explants between the 3rd and the 4th and the 2nd and the 3rd endogenous 
mammary rudiment. Application of recombinant Eda protein to wild type explants induces a 
phenotype mimicking K14-Eda. (Scale bar: 100 μm)
Ex vivo culture for observing later stages of mammary morphogenesis was fi rst described in 
the late 1960s by Klaus Kratochwil (Kratochwil, 1969). His work revealed that the mammary 
rudiments are unable to sustain or induce their development in the absence of the underlying 
mesenchyme. He showed that the embryonic rudiments from several stages ranging from E11.5 
to E15.5 could be maintained in culture conditions for up to nine days. Th e method relied on 
isolation of the mammary epithelium from the epidermis and mechanical scraping of the ventral 
mesenchyme that was used as a substrate to support epithelial morphogenesis (Kratochwil, 1969). 
A highly similar approach was utilized by Hens and colleagues for studying downstream eff ects 
of Pthrp (Hens et al., 2009;Hens et al., 2007). Whereas the described methods were obviously 
functional, we found them to be time consuming and the rate of successful development to be 
inconstant. Th e particular challenge of the procedure was the manual gathering of the ventral 
mesenchyme, which easily damaged the sensitive embryonic tissue. However, previous studies 
** * **
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have reported that by applying appropriate enzymatic processing it is possible to separate the 
embryonic epithelial and mesenchymal compartments without causing irreversible tissue 
damage (Drews and Drews, 1977). 
In order to analyse factors aff ecting embryonic mammary gland branching more carefully, 
we developed a novel ex vivo mammary bud culture method. We modifi ed the procedures 
described above by combining them with enzymatic separation of the epithelium and 
mesenchyme. We used pancreatin-trypsin as the proteolytic enzyme, but also dispase could 
be optimized for this purpose. We chose to use E13 stage explants for two particular reasons. 
First, at this time the androgen-mediated destruction of the male mammary rudiment has not 
yet initiated, which enables the use of all embryos regardless of their gender. Second, at E13 the 
branching morphogenesis has not commenced, which permits manipulation and detection of 
the ductal development from early stages.
To harvest an explant from the embryo, I dissected ventral fl anks that contained both 
epithelial and mesenchymal compartments of the mammary forming region, and most oft en 
mammary buds two, three and four. Th e explants were treated with pancreatin-trypsin and 
the enzymatic activity was terminated by 10% FCS. Aft er a short recovery from the proteolytic 
processing, the epidermis was peeled off  from the mesenchyme. Despite the separation of the 
epidermis, the epithelial mammary buds typically stayed attached to the mesenchyme. Th is 
gave rise to an explant that comprised the ventral fl ank mesenchyme together with epithelial 
mammary buds at their original locations. At E13, the epidermis is still transparent and 
mammary rudiments are readily detected from whole mount embryos. During the following 
days, the epidermis keratinizes and thickens. Were it not removed prior to the culture period, it 
would eventually hinder the detection and visualization of the ductal development. 
At E13, mammary buds are morphologically fairly quiescent and branching morphogenesis 
does not commence until at E16-E17 (Cowin and Wysolmerski, 2010;Veltmaat et al., 2003). 
Accordingly, during the fi rst three days of the culture (E13+3d) the mammary buds merely grew 
in size but did not exhibit any other obvious morphological changes. On the fourth day, the 
mammary bud had adopted a more elongated structure, which would indeed correspond to the 
E16 stage and formation of the primary sprout. By the fi ft h day (E13+5d), the mammary rudiments 
showed more advanced ductal development and most oft en several distinct ductal tips. With wild 
type explants, the method yielded success rates from 70% to 90% depending on the mouse strain. 
4.2 Eda promotes mammary placode formation and enhances 
prepubertal branching morphogenesis (II, III)
Eda is dispensable in the earliest stages of mammogenesis; Eda null embryos develop all fi ve pairs 
of mammary placodes in conserved positions (Pispa et al., 2008). Transgenic overexpression of 
Eda (K14-Eda mice) gives rise to supernumerary mammary placodes along the milk line (Figure 
6) that develop into small ductal trees and are associated with nipples in the adult animal. To 
better understand the eff ects of Eda on hormone-independent mammary gland development, we 
analysed both Eda gain- and loss-of-function mammary primordia at several prepubertal stages. 
We utilized whole mount in situ hybridization (WMISH) for several placode markers in addition 
to morphological analysis to visualize placode formation. 
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Figure 6. Whole mount in situ hybridization for Wnt6. 
Wnt6 is expressed in the endogenous mammary buds of wild type, K14-Eda and Eda −/− embryos. 
By E13.5, supernumerary mammary placodes (*) have emerged in the mammary-forming region in 
K14-Eda background and likewise express Wnt6. (Scale bar: 500 μm)
Induction of the endogenous mammary placodes between E11 to E11.5 did not present 
noticeable defects between Eda −/− and wild type. Likewise, the endogenous mammary placodes 
in K14-Eda embryos developed seemingly normally and in appropriate positions. 
Characterization of the supernumerary mammary placodes in K14-Eda mice revealed 
that their development was delayed compared to the endogenous rudiments as previously 
reported (Mustonen et al., 2004). By E13 stage the expression of several placode markers became 
restricted to the accessory structures. Traditionally the milk line that possesses the capability to 
generate mammary primordia has been considered to cover the regions between the fore and 
hind limbs (Veltmaat et al., 2004). Surprisingly, we found that K14-Eda mice develop ectopic 
placodes in the neck, an area previously not known to possess mammary gland potential. 
Unlike the supernumerary structures of the fl ank, the placode pair in the collar section 
initiated its development nearly simultaneously with endogenous placodes. Curiously, our in 
situ hybridization analysis of E11.5 wild type and K14-Eda embryos revealed a cluster of Dkk4 
and Wnt10b positive cells in the neck region of both genotypes. In wild type embryos the focal 
expressions were only transient, but in K14-Eda embryos they were sustained. Th ese results 
could indicate that a mammary pre-placode forms regularly in the neck of wild type embryos. 
However, only elevated Eda levels appear to stabilize their further growth. Taken together, this 
suggests that the potential milk line in fact extends further that previously described. 
Mutations of the Eda signalling pathway lead to a wide spectrum of characteristics from 
completely abolished development to milder alterations in organ formation (Mikkola, 2009). 
Eda has also been shown to fi ne-tune the development of several ectodermal organs (Sadier et 
al., 2014). Upregulation of the signalling output oft en increases placode size and number and 
alters the shape of the future organ (Häärä et al., 2011;Harjunmaa et al., 2012;Mustonen et al., 
2004;Sadier et al., 2014). Our results show that upregulation of Eda has very similar eff ects on 
mammary placode formation. Early Eda −/− and K14-Eda phenotypes suggest that mammary 
induction is independent of the pathway. Instead, modulation of the Eda levels is more likely able 
to boost the existing potential residing along the entire milk line. 
Quantitative analysis of E14.5 K14-Eda mammary bulbs confi rmed a prominent increase 
in epithelial volume and cell proliferation. High proliferation coincided with precocious branch 
formation in the ductal epithelium in K14-Eda background. At E15.5 the wild type and Eda 
null rudiments were still at a bulb stage, as expected (Propper et al., 2013), whereas K14-Eda 
primordia had already elongated and the formation of the fi rst branches was evident in the 
most advanced pairs. By E16.5, the transgenic ducts had developed into a small ductal tree that 
resembled new-born wild type glands. 
Materials and methods
** *
wt K14-Eda Eda-/-
mb1
mb2
mb3
mb4
mb5 Wnt6
E13.5
27
At the onset of branching morphogenesis, between E15 to E17, expression of Edar was 
detected in the mammary epithelium, whereas Eda transcripts were localised to the surrounding 
mesenchyme. Classic tissue recombination studies have shown that the mammary rudiment is 
unable to develop in the absence of the mammary mesenchyme, which suggests that the branching 
pattern is determined by the mesenchyme (Dunbar et al., 1998;Kratochwil, 1969;Sakakura et al., 
1976). Yet the precise role of many mesenchymal signals remains poorly understood, and most 
likely several are still waiting to be discovered. Few of the studied mesenchymal factors include 
somitic Fgf10 and Nrg3 that are found in the mesenchyme prior to placode induction (Howard et 
al., 2005;Mailleux et al., 2002). Later, Fgf10 is present in the fat pad precursor cells. Additionally, 
Fgf7 is expressed fi rst in the primary mammary mesenchyme and is later co-expressed with 
Fgf10 in the future fat pad compartment (Mailleux et al., 2002). Our results indicate that Eda 
is a novel mesenchymal factor that regulates mammary morphogenesis in a paracrine manner 
through activation of the epithelial Edar receptor. 
Examination of the prenatal mammary glands at E18 revealed signifi cant diff erences 
in epithelial ductal morphogenesis between all the genotypes. Eda loss-of-function led to a 
reduction in the amount of branches (68%), whereas a dramatic fi ve-fold increase was observed 
in K14-Eda glands. Analysis of prepubertal 3-week-old mice confi rmed that the detected 
phenotypes were not transient (Figure 7). K14-Eda animals displayed a three-fold increase in 
the number of ductal tips as compared to wild type controls, and in contrast an overall 54% 
reduction in the number of ductal termini was observed in Eda −/− animals. Taken together, this 
shows that embryonic and prepubertal branching correlates with the amount of Eda. 
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Figure 7. Branching morphogenesis in 3-week-old mice. 
Th e branching morphogenesis correlates with the amount of Eda. K14-Eda exhibit increased 
amount of ductal tips whereas Eda−/− have fewer branches compared to wild type (Carmine alum 
stainings of mammary gland number 4). (Scale bar: 1 mm)
Despite the prominent increase in the size of the K14-Eda ductal tree at E18, the glands displayed 
a relatively typical mammary gland branch pattern. By birth, mammary glands two and three 
are always characterized by a more advanced ductal morphology than the rest of the rudiments 
(Veltmaat et al., 2003). Th e same asynchronous development was conserved in K14-Eda glands. 
Th is suggests that the observed increase in epithelial proliferation accelerating the branching 
morphogenesis is the main means for changes in ductal development. Similarly, analysis of Eda 
gain- and loss-of-function submandibular salivary gland has previously shown that Eda levels 
aff ect the branching morphogenesis of the organ but preserve the branch pattern typical to 
salivary glands (Häärä et al., 2011).
wt K14-Eda Eda-/-
3wk
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Th e ex vivo culture recapitulated the branch pattern of diff erent mouse models. K14-Eda 
mammary rudiments showed a precocious and clearly more advanced branch phenotype aft er 
fi ve days of culture compared to the wild type (Figure 8). However, Eda −/− mammary buds were 
most oft en unable to sustain their development ex vivo, indicating that the culture environment 
was somewhat harsher than in vivo conditions. Application of Fc-Eda however increased the 
percentage of successful ductal outgrowth from 10% to 50%.
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Figure 8. Ex vivo culture of E13.5 mammary buds.  
Aft er fi ve days of culture the mammary buds have undergone branching morphogenesis that is 
signifi cantly more advanced in K14-Eda explants. Th e mammary rudiments, thus, recapitulate the 
in vivo mammary phenotypes of the strains. (Carmine alum stain of mammary rudiments 2 and 3). 
(Scale bar: 250 μm)
Th e precise time window for Eda’s function remains as of yet undetermined. Our analysis of 
Eda gain-of-function mammary glands has been conducted in a mouse model in which Eda is 
overexpressed as early as E9.5 and onwards. Th e activation of the transgene prior to mammary 
placode formation might, thus, aff ect the number of mammary progenitor cells, which in turn 
could give rise to the observed ductal phenotype. However, the ability of recombinant Eda 
protein (Fc-Eda-A1) to rescue ductal outgrowth of Eda −/− mammary buds ex vivo points towards 
a regulatory function during ductal morphogenesis. Creation and investigation of inducible 
gain- or loss-of-function mouse models could clarify the issue in the future. Alternatively, ex vivo 
application of Fc-Eda, agonistic anti-Edar, or function-blocking anti-Eda antibodies (Kowalczyk-
Quintas et al., 2014;Kowalczyk-Quintas and Schneider, 2014) at diff erent time points could be 
utilized to pinpoint the exact role of Eda at various developmental stages.
A recently-generated mouse knock-in model of the human EDAR gain-of-function 
variant (V370A) has been shown to exhibit an increase in the mammary branch density during 
adolescence (Kamberov et al., 2013). Th e mouse recapitulates many features associated to the 
variant in human populations (Kamberov et al., 2013). Similarly, transgenic mice with enhanced 
Edar signalling (EdarTG951) as a result of a high copy number of the wild type Edar locus, show 
escalated ductal morphogenesis in adulthood. Th e same study likewise reported decreased 
branching in response to loss of Eda or Edar (Chang et al., 2009). Th ough these reports did 
not focus on prepubertal development, they suggest that ductal branching correlates with Eda 
levels and the eff ects might be similar in humans. Since the Eda pathway is oft en dispensable 
wt K14-Eda
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for initiation of glandular organs (Gruneberg, 1971), including mammary glands, and instead 
necessary for epithelial growth and branching, it might be utilized in adaptive evolution to 
elevate the function of exocrine glands by increasing epithelial secretory area. 
Breast defects associated with HED have not been extensively studied in human patients. 
Mammary glands mature to their functional form only upon pregnancy, and the identifi cation 
of possible morphological defects that result in impaired lactation is hence bound to the 
individual’s reproductive history. For this reason, the defects may remain latent for decades or 
never surface. Shortcomings in salivary and sweat gland function have more profound impact 
on the quality of everyday life, whereas aesthetic eff ects of sparse hair and malformed teeth are 
more self-evident. Th us far only one study has reported diffi  culties related to lactation in XLHED 
carriers. Insuffi  ciency in milk production was extremely common (Clarke et al., 1987). However, 
these results were not compared to a control group of women. An unpublished study by National 
Foundation for Ectodermal Dysplasia (NFED) revealed that HED has profound and thus far 
unrecognized eff ects on breast development and lactation. According to the study, 35% of female 
HED patients have absent or hypoplastic nipples and only one third are able to breastfeed. 
Th is, together with individual case reports on mammary hypoplasia in association with HED, 
suggests that breast abnormalities are a frequent manifestation of the syndrome (Haghighi et al., 
2013;Megarbane et al., 2008;NFED, 2012), but perhaps was previously neglected as the majority 
of the individual aff ected by HED are males. 
Our results showing defects in prepubertal Eda −/− branching morphogenesis, and the report 
with a similar phenotype in post pubertal glands (Chang et al., 2009) suggest that a reduction of 
epithelial breast tissue could account for the described symptoms in humans. Role of Eda during 
pregnancy-induced tertiary branching has not been studied, and thus it cannot be excluded that 
impaired alveologenesis could bring about diffi  culties in breastfeeding. Normally Eda −/− mice are 
capable of feeding their young indicating that pregnancy-induced mammary gland maturation 
must be intact at least to some extent. However, a recently described rat model for HED, which 
harbours a loss-of-function mutation in the Edaradd, presents impaired alveolar growth and 
hypoplastic mammary glands (Kuramoto et al., 2011), which might indicate a possible role for 
Eda in pregnancy-associated ductal development. 
4.3  NF-κB mediates effects of Eda during mammary primordia 
development (II, III)
Transcription factor NF-κB is believed to be the main downstream eff ector of Eda in many 
ectodermal organs (Mikkola, 2009). Th is conclusion is further strengthened by phenotypic 
similarities between Eda −/− and a mouse model with supressed NF-κB activity (IκBαΔN 
mice) (Schmidt-Ullrich et al., 2001). However, involvement of the JNK pathway has also been 
suggested by in vitro studies (Kumar et al., 2001), and other downstream mediators commonly 
activated by other Tnfrs cannot be excluded. Th e necessity of NF-κB in embryonic mammary 
gland development has thus far remained largely unexplored. According to a previous report, 
mammary epithelium displays high, Eda and Traf6 -dependent, NF-κB activity (Dickson et 
al., 2004;Pispa et al., 2008). We analysed NF-κB reporter expression in control and K14-Eda 
littermates to elucidate the spatiotemporal control of NF-κB activity and characterized how the 
involvement of Eda contributes to it. 
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At E11, the NF-κB activity was localized to the emerging mammary placodes and was 
fairly similar between the wild type and K14-Eda embryos. By E11.5, both genotypes exhibited 
a continuous stripe of low-level reporter-positive cells which combined the entire milk line 
region and was upregulated in the mammary primordia. From this stage onwards, NF-κB 
activity appeared to become downregulated in the intra-placodal region of wild type embryos, 
whereas more intense reporter activity was evident in the corresponding region in the K14-Eda 
embryos. By E13, low-level NF-κB activity had confi ned to supernumerary placodes in K14-Eda 
embryos. Th e ectopic placodes of the neck and the supernumerary placodes between the third 
and the fourth mammary bud exhibited a mosaic reporter expression. We also observed that the 
magnitude of NF-κB activity was dependent on Eda levels; Eda−/− mammary rudiments displayed 
no NF-κB activity, in wild type mice the reporter expression became confi ned to the basal cells 
from the bud stage onwards, and in K14-Eda embryos the entire mammary epithelium was 
characterized by ectopic reporter expression at multiple developmental stages. 
In order to further understand the eff ects of NF-κB in mammary development, we utilized 
the IκBαΔN mouse line. Th e strain expresses non-degradable super-repressor IκBα ubiquitously, 
which leads the suppression of NF-κB activity (Schmidt-Ullrich et al., 2001). Similarly to Eda −/− 
mice, IκBαΔN animals retain all fi ve pairs of mammary glands, and placodes form at conserved 
positions. At E18, IκBαΔN mammary glands exhibited a 48% decrease in ductal tip number 
compared to wild type littermates, and approximately the same diff erence was maintained 
at 3weeks of age. Th is indicated that NF-κB regulates normal embryonic ductal development, 
though it is not necessary for placode induction.
Compound K14-Eda and IκBαΔN embryos, however, revealed that the formation of 
supernumerary mammary primordia was dependent on NF-κB. Th e accessory structures and 
localized gene expression of all studied placode markers were absent in K14-Eda/IκBαΔN 
mutants. Additionally, we found that the hyperbranched K14-Eda ductal phenotype was 
normalized in the IκBαΔN background in E18 and 3-week-old mice. Th is clearly shows that 
NF-κB is a major transducer of Eda-induced placode formation and ductal branching. However, 
based on our results, the possible existence of other downstream pathways, whose function 
might merely be concealed by the loss of NF-κB, cannot be excluded. Th eir impact on mammary 
gland development would most likely be minor compared to eff ects brought about by NF-κB.
Th e presence of NF-κB in several stages of mammary gland morphogenesis is well 
established. Over the course of normal postnatal life, including pregnancy, lactation and 
involution, several NF-κB subunits and the main inhibitor, IκBα, are expressed in the mammary 
epithelium (Brantley et al., 2000;Cao and Karin, 2003;Clarkson and Watson, 1999). Th e mouse 
model for supressed NF-κB activity, which expresses non-degradable IκBα under the MMTV 
promoter, exhibits an early but transient delay in ductal branching during pregnancy (Demicco et 
al., 2005), whereas knock-in mice with a defective IKK complex display impaired alveologenesis 
(Cao et al., 2001;Demicco et al., 2005). Mice that lack the gene encoding for NF-κB suppressor 
IκBα (NF-κB gain-of-function) die perinatally. However, transplantation studies of the transgenic 
epithelium into wild type fat pads have demonstrated that increased NF-κB activity augments 
lateral ductal branching and hyperplasia (Brantley et al., 2001). Overall these and other studies 
highlight the importance of correct NF-κB pathway activity in mammary gland development 
and function. 
NF-κB regulates growth, diff erentiation, and apoptosis in several tissues (Perkins, 2007). Th e 
high proliferation rates in K14-Eda mammary rudiments at the onset of branching morphogenesis 
would indicate that Eda/NF-κB exerts its eff ects through the increase of proliferation similarly to 
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NF-κB in postnatal development. Given the broad developmental roles and multiple target genes 
governed by NF-κB, it becomes clear that careful regulation of the transcription factor activity 
is necessary (Hayden MS 2006). Uncoupling NF-κB from normal regulation could contribute to 
tumorigenesis and metastasis (Shostak and Chariot, 2011). Indeed, NF-κB has been shown to be 
misregulated in several breast cancers. Numerous studies have reported an elevation of NF-κB 
activity in both mammary carcinoma cell lines and in diff erent human breast cancer tissues 
(Cogswell et al., 2000;Nakshatri et al., 1997). Th us far Eda signalling has not been implicated 
in various breast cancers. However, an unpublished report described in a meeting abstract has 
associated enhanced Edar signalling with pregnancy-induced mammary tumours in mouse 
(Jobling et al., 2009). Whether misregulation of the pathway has a connection to breast cancer 
incidences will undoubtedly be uncovered by future studies. 
4.4 Identification of Eda/NF-κB downstream targets in 
mammary primordia (II, III)
Transcriptional targets of Eda have thus far been analysed mainly in embryonic or adult skin (Cui 
et al., 2002;Cui et al., 2006;Fliniaux et al., 2008;Lefebvre et al., 2012;Mou et al., 2006), whereas 
genes regulated by Eda in mammary glands have remained largely unknown. We fi rst set out to 
assess potent Eda target genes in the embryonic mammary bud with a candidate gene approach, 
which was based on a microarray, performed on genes diff erentially expressed in embryonic E14 
Eda−/− back skin upon short exposure to recombinant Eda (Fliniaux et al., 2008;Lefebvre et al., 
2012), as well as on other reports on Eda target genes in hair follicles (Zhang et al., 2009). Th ese 
studies had implicated PTHrP and Egfr ligands Areg and Epgn as potent Eda target genes, and 
provided evidence of Wnt agonists Wnt10a and Wnt10b being NF-κB target genes in the hair 
placode. 
We utilized a similar setup to induce upregulation of the Eda downstream targets in the 
mammary bud by exposing rudiments from E13.5 Eda −/− embryos to Fc-Eda. Quantitative 
RT-PCR (qRT-PCR) analysis of Fc-Eda treated mammary confi rmed a signifi cant increase in 
Wnt10a, Wn10b and Pthrp levels compared to untreated control samples, but only low-level 
upregulation of Areg and Epgn. Dkk4 that has previously been identifi ed as an Eda target gene 
(Fliniaux et al., 2008) was also highly upregulated in mammary primordia in response to Eda. 
Whole mount in situ hybridization (WMISH) analysis further showed that Pthrp and Wnt10b 
expression correlated with Eda levels in mammary primordia. 
Next, we performed microarray profi ling on E13.5 Fc-Eda treated (4h) Eda −/− mammary 
buds. Th e Eda treatment caused upregulation of 245 and downregulation of 78 genes. Among 
them were members of several distinct signalling pathway families such as Wnt, Fgf, Tnf, 
Tgf-β, chemokines and Hedgehog. In addition, adhesion molecules Icam1 and Madcam1, 
metalloproteinases Mmp9 and Adamts-15, and transcription factor Foxi3 were induced by Eda. 
We validated the microarray results on selected upregulated genes with qRT–PCR and WMISH. 
Transcription factor Foxi3 was among the highly upregulated genes. It has previously 
been shown to be induced by Eda in developing hair follicles and teeth as well as transiently in 
mammary buds (Shirokova et al., 2013). Other upregulated genes were Fgf20 and Fgf17. Fgf20 
has been identifi ed as an Eda target gene in developing hair and teeth (Häärä et al., 2012;Huh et 
al., 2013). During mammogenesis, several Fgf genes are expressed in the mammary epithelium 
and/or in the adjacent epidermis (Eblaghie et al., 2004). Th ough mesenchymal Fgf10 and 
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epithelial receptor Fgfr2b have distinct roles in mammary induction (Mailleux et al., 2002), the 
importance of the other Fgfs is not yet well-understood and further studies will be required to 
uncover their precise roles. In addition to the previously identifi ed Wnt pathway factors, we 
found Wnt inhibitor Kremen2 and R-spondin receptor Lgr4 to be among the genes regulated by 
Eda. 
Even though qRT-PCR confi rmed signifi cant upregulation of Adamts15, Icam1, Madcam1 
and Mmp9, none of the factors were detected by WMISH in wild type mammary buds. However, 
Madcam1 and Mmp9 were detected in K14-Eda primordia suggesting that they lie downstream 
of Eda in mammary buds. Madcam1 and Icam1 have been reported to be upregulated in the 
embryonic skin in response to Eda treatment (Lefebvre et al., 2012), but their possible signifi cance 
to mammary gland development is unknown. Mmps have previously been linked to mammary 
gland branching morphogenesis (Simian et al., 2001). During embryonic mammogenesis, ex 
vivo inhibition of Mmp activity blocks ductal outgrowth and specifi cally Mmp2 has been shown 
to stimulate ductal growth (Hens et al., 2009). However, Mmp9 defi ciency does not impair 
mammary gland development (Wiseman et al., 2003), possibly due to redundancy with other 
Mmps. 
Identifi cation and successful validation of several distinct factors implies that Eda may act 
by tinkering the activity of multiple mammary-associated pathways during morphogenesis. 
Overall, our results were in line with previous fi ndings that had identifi ed Eda-induced genes in 
hair placodes. We found many shared genes between the analyses (Fliniaux et al., 2008;Lefebvre 
et al., 2012). Although these studies cannot be directly compared due to diff erent microarray 
platforms used, it seems that the gene regulatory network governed by Eda is largely shared 
between hair follicles and mammary glands.
4.5 Eda upregulates Wnt activity which mediates its effects on 
mammary primordia (II, III)
Eda and Wnt signalling pathways have been shown to be intertwined during tooth, hair and 
salivary gland morphogenesis (Häärä et al., 2011;Mikkola, 2009), but their possible cooperative 
role in nascent mammary gland has not been explored. Since several components of the Wnt 
pathway were shown to be induced by Eda, and studies on hair placodes had proposed that one 
of the functions of Eda is to sustain canonical Wnt signalling activity (Zhang et al., 2009), we 
evaluated whether the Wnt pathway could be an important downstream eff ector of Eda signalling 
also in mammary morphogenesis. 
We analysed expression patterns of many Wnt pathway genes that were upregulated in the 
microarray and had been validated by qRT-PCR. Our WMISH analysis revealed that several 
of them were upregulated in the supernumerary mammary-forming region early on. Wnt10b, 
Lgr4, Krmn2 and additionally β-cat displayed a continuous streak of expression in the fl ank 
already at E12.5. Th e expression patterns were transient and only half a day later, the expression 
of these genes became confi ned to the emerging supernumerary placodes. We also studied the 
expression of other genes associated with placode formation (Nrg3, Fgf2rb and Tbx3). However, 
we were unable to establish any link between them and Eda signalling. To further test the eff ect 
of Eda on Wnt pathway activation, we turned to tissue culture. Ex vivo application of Fc-Eda to 
E12.5 TopGal reporter ventro-lateral skin explants induced an increase in reporter-positive cells 
between the third and the fourth mammary bud.
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Next, we utilized the tissue culture setup to grow K14-Eda skin fl anks that gave rise to 
supernumerary placodes similarly to in vivo. Introducing Wnt inhibitor XAV939 (Huang et al., 
2009) to the culture system suppressed formation of the accessory structures in a dose-dependent 
manner. Higher concentrations fully inhibited supernumerary placode formation, whereas 
lower amounts of the molecule permitted some of the structures to emerge. Taken together, this 
indicates that Wnts are important eff ectors of Eda in supernumerary placode induction. Wnt 
activity has also previously been implicated in accessory mammary placode formation. Artifi cial 
activation of the pathway with LiCl gives rise to placode-like structures ex vivo (Chu et al., 2004). 
During mammary primordia development, TopGal reporter activity is found along the milk 
line from E10.5 onwards (Chu et al., 2004). It thus precedes NF-κB activity that is absent from the 
mammary-forming region prior to E11. Our results show that even though Eda is not originally 
required for the induction of Wnts, later on its levels modulate expressions of several individual 
Wnt pathway factors. However, Wnt pathway activity or maintenance is not solely dependent 
on Eda. Taken together, this places Wnts upstream of Eda signalling in mammary induction. 
Aft er the placodes have formed, Eda potentiates and modulates Wnt activity by upregulating the 
activators and inhibitors of the pathway. Upregulation of Wnt inhibitors suggests a presence of a 
negative feedback signalling. Th is could be a means for regulating placode size and to ensure that 
the primordia do not develop too close to each other. In conclusion, Eda-dependent increase in 
Wnt signalling activity, most likely via upregulation of multiple Wnt pathway genes, is the likely 
cause for induction of supernumerary mammary placodes in K14-Eda mice.
We also considered whether Eda-induced upregulation of Wnt agonists could explain the 
enhanced ductal development of K14-Eda mice. Indeed, it has been shown that transgenic 
overexpression of Wnt10b under MMTV-promoter results in a hyperbranched ductal phenotype 
in adult animals (Lane and Leder, 1997). On the contrary, genetic ablation of Lgr4 impairs adult 
branching morphogenesis (Wang et al., 2013). Similarly, mutations of Lrp5 and Pygopus2 that 
decrease Wnt signalling output result in stunted ductal phenotypes during embryogenesis. We 
analysed Wnt10b expression by in situ hybridization, which showed Eda-dependent correlation 
at the onset of branching morphogenesis. We also compared TopGal and BatGal Wnt reporter 
expressions at the onset and during branching morphogenesis between wild type, K14-Eda and 
Eda null mammary primordia. Curiously, reporter expression appeared to be downregulated 
in the K14-Eda mammary epithelium but upregulated in the mesenchyme. Moreover, 
immunohistochemical analysis of Lef1 exhibited similar correlation. As Eda upregulates both 
Wnt agonists and antagonists, the detected opposing eff ects of Eda in the epithelium and the 
mesenchyme could refl ect the function of these diff erent factors in separate tissue compartments. 
Conclusions should, however, take into account that the K14-Eda glands exhibit a more advanced 
ductal phenotype. Some of the observed diff erences might be a refl ection of normal diff erences 
between morphological stages.
We also assessed the eff ects of increased Wnt activity in tissue culture. However, ex vivo 
activation of the Wnt pathway with Wnt3a recombinant protein was not able to compensate for 
the lack of Eda and rescue the impaired ductal phenotype of Eda null mammary rudiments. 
Nevertheless, Wnt3a did increase ductal branching in wild type primordia. Most likely the 
accelerated branching witnessed in K14-Eda background is a consequence of combinatory eff ects 
of Wnt signalling and some other Eda induced factor(s). Th ese may include PTHrP and Egfr 
agonists, which all accelerated ductal growth and branching of wild-type mammary buds ex vivo. 
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4.6 Overexpression of Eda leads to loss of sexual dimorphism 
in the mammary glands (III)
In mice the sexual dimorphism of the mammary glands occurs during embryogenesis due to 
AR-mediated apoptosis at E14 (Dunbar et al., 1999;Kratochwil and Schwartz, 1976;Kratochwil, 
1977). Unexpectedly, we found that the K14-Eda males possess mammary glands and nipples 
even in adulthood. Examination of the K14-Eda male mammary primordia at E18 revealed a 
clearly more advanced ductal morphogenesis compared to wild type female glands and a very 
close resemblance to K14-Eda female rudiments. We also observed a similar situation in 3-week-
old prepubertal animals. Th e diff erences between K14-Eda female and male glands only appeared 
at the onset of puberty. Th e oestrogen-mediated growth burst of the glands occurred in the 
females but was never witnessed in the male mice. Th ese observations indicate that the hormonal 
control of the gland development is most likely preserved. Expectedly, ductal structures were 
absent or severely stunted in control males. 
At E15.5, the stalk region of the K14-Eda male mammary bulb exhibited an extremely 
narrowed morphology due to mesenchymal condensation which is typical for wild type males 
of a similar stage. Immunohistochemical analysis revealed no abnormalities in the mesenchymal 
AR expression or apoptosis of the epithelial stalk in K14-Eda males. A probable explanation for 
the uninterrupted epithelial morphogenesis in the animals is the precocious and more advanced 
ductal development compared to the wild type. At E14, the wild type rudiment is still at the 
bulb stage, whereas the K14-Eda gland has already invaded through the AR-positive primary 
mammary mesenchyme into the fat pad precursor, AR free, compartment. Most likely these 
ductal tips are able to escape the androgen-mediated apoptosis and continue their development 
as blind ducts that have a severed connection to the upper epidermis. 
Formation of the nipple sheath, which gives rise to the nipple, is thought to be dependent on 
cues originating from the mammary mesenchyme (Dunbar et al., 1998). Curiously, the apoptotic 
destruction of the mammary mesenchyme does not interfere with nipple sheath development, as 
K14-Eda males retain nipples. Th is indicates that the mammary mesenchyme must remain intact 
in K14-Eda males at least to some extent. Perhaps the amount of the specialized mesenchymal 
tissue in K14-Eda embryos is higher than in the wild type counterparts, and the androgen-
mediated apoptosis does not destroy it completely. As the K14-Eda glands represent a more 
advanced developmental stage already at E14, it is also possible that the mammary mesenchyme 
has had suffi  cient time to instruct the nipple sheath to form by E14. However, additional studies 
would be required to verify the theory.
Th ese results demonstrate that during embryogenesis the mammary microenvironment is 
very similar between male and female mice. Male glands are able to continue their development 
as long as they manage to reach the secondary mammary mesenchyme. Th e epithelial-
mesenchymal interactions between the ductal tips and the fat pad precursor cells obviously are 
intact, as branching morphogenesis takes place even in the blind ducts of K14-Eda males. 
Loss of sexual dimorphism has also been described in a few other mouse strains. Pthrp 
null mice maintain mammary gland development beyond the E14 stage. AR expression in 
the primary mammary mesenchyme is dependent on Pthrp signalling, and in its absence the 
androgen-mediated receptor activation and following apoptosis in the primordia never takes 
place (Dunbar et al., 1999). A similar situation occurs in Gli3−/−mice in which AR expression is 
diminished and the males of the strain retain mammary sprouts to some extent (Chandramouli 
et al., 2013). Transgenic male mice that express human aromatase enzyme have abnormally low 
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testosterone and high oestrogen levels. Th e hormonal imbalance induces ductal development 
also in the male mice (Li et al., 2002).  
Th ese circumstances, however, diff er from the one observed in K14-Eda males that have 
normal AR expression and activation. A previous report has shown that the Wnt10b gain-
of-function mouse strain exhibits mammary development that involves highly-branched 
mammary ducts in both genders. Th is implies that the increased Wnt10b levels enable the male 
mammary rudiments to bypass the embryonic destruction of the organs. A similar phenotype 
is also observed in Wnt1 transgenic males (Lane and Leder, 1997;Tsukamoto et al., 1988). We 
have identifi ed Wnt10b as one of the potent downstream targets of Eda signalling and shown 
that ectopic activation of the Wnt pathway increases and/or accelerates embryonic ductal 
morphogenesis ex vivo. It is thus possible that the phenotypic similarities between the K14-Eda 
and the above-described Wnt gain-of-function strains originate from shared developmental 
characteristics.
Why males of certain mammalian species retain nipples and mammary glands, whereas in 
others development is supressed already during embryogenesis, is not well understood. However, 
in all mammals the gland formation commences, as a default developmental program, before 
the gender-specifi c characteristics emerge. Most likely the importance of mammary glands for 
future off spring survival is so vital, whereas the presence of unnecessary glandular structure is so 
insignifi cant, that there has not been high enough selective pressure to erase them from males. 
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5 Concluding remarks
Th is thesis work has focused on elucidating the role of Eda in the prepubertal mammary 
gland development. We found that Eda has a dual role in mammogenesis. First, Eda induces 
supernumerary mammary placode formation within the milk line (Mustonen et al., 2003) and in 
the neck, an area that has not previously been described to possess mammary induction capacity. 
Second, branching morphogenesis of the nascent gland correlates with the amount of Eda. 
Whether the Eda-dependent alterations in ductal morphogenesis are retained during hormonal 
development was not examined. However, a recent study of adult Edar gain-of-function and 
Eda-/- and Edar-/- mice would suggest that Eda levels aff ect branching morphogenesis also 
during later, postnatal stages of development or that the morphological diff erences originating 
from embryogenesis are sustained (Chang et al., 2009). 
Transcription factor NF-κB is thought to be a major mediator of Eda signalling (Mikkola, 
2009). We showed that NF-κB activity contributes to prepubertal branching morphogenesis 
and is crucial for Eda-induced accessory placode formation and accelerated branching 
morphogenesis. Th is indicates that NF-κB is the main downstream transducer of Eda signalling 
also in the mammary gland. We identifi ed several potent transcriptional targets of Eda/NF-κB 
signalling. Some of these genes had previously been shown to be regulated by Eda/NF-κB in other 
ectodermal organs (Lefebvre et al., 2012;Zhang et al., 2009). Th is indicates that genetic networks 
governed by Eda are shared between diff erent ectodermal organs at least to some extent. We 
discovered that Wnt/β-cat signalling is an important downstream eff ector of Eda/NF-κB. Th e 
formation of supernumerary mammary placodes and accelerated ductal development in wild 
type primordia were dependent on the pathway activity. However, other factor(s) are bound to 
be involved in mediating Eda’s eff ects in prepubertal mammary gland. 
Considering the variety in the number of mammary glands present in diff erent mammals, 
one might speculate that modulation of the Eda pathway could be an evolutionary means to 
increase or restrict the number of the organs. Th e K14-Eda mice display a curious likeness 
for example to the multimammate mouse (Mastomys) that have equally spaced nipples along 
the ventral surface from the axilla to inguinal region. Formation of supernumerary nipples is 
fairly common in humans and other studied mammals (Kajava, 1915). Misregulation of the Eda 
pathway could account for at least some of these malformations. 
Mammary gland defects associated with XLHED and autosomal HED are only now being 
characterized more intensively. Our results suggest that the glandular tissue of the breast could 
be defective in the aff ected patients, as the preliminary NFED report appears to indicate. Our 
results suggest that the defects arise already during neonatal development. However, whether 
Eda has an eff ect on pregnancy-induced branching, a prerequisite for successful lactation is still 
unknown. It is also possible that the defective lactation is a combination of embryonic defects 
and impaired ductal development during pregnancy. NF-κB activity during the hormone-
dependent morphogenesis is well documented, and it would be interesting to fi nd out whether 
Eda mediates some of the eff ects. 
To conclude, the mammary gland is an interesting experimental system for several 
reasons. Th e embryonic development off ers possibilities to study various important phenomena 
including organ induction, epithelial-mesenchymal interactions, ductal invasion and branching 
morphogenesis in addition to associated cellular mechanisms, such as cell proliferation 
and migration. Th e described ex vivo methods for culturing mammary primordia enable the 
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evaluation of individual proteins, inhibitors or other small molecules during diff erent stages of 
mammary gland development. In both procedures described, mammary buds are retained in 
their original locations, which could also enable assessment of the stromal microenvironment. 
Ex vivo culture of explants harbouring fl uorescently labelled mammary cells should permit live-
imaging of the tissue even at a single-cell resolution, as previously shown for e.g. developing hair 
follicles (Ahtiainen et al., 2014). Th is approach is bound to reveal many details about embryonic 
mammogenesis. Considering the high prevalence of breast cancer and the parallel characteristics 
between embryonic mammary gland development and breast tumorigenesis, understanding 
the cellular and morphological mechanisms that control normal ductal development and 
microenvironment is increasingly important.
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